0
21
FOCUS, VOL. 1, No. 4
1
REVIEW   |   October 01, 2003 
The Law and Psychiatry
Robert I. Simon, M.D.
1From the Program in Psychiatry and Law, Georgetown University School of Medicine, Washington D.C.
FOCUS 2003;1:349-372.
View Article Information
Dr. Simon has no financial affiliations with commercial organizations that may have direct or indirect interest in this CME program.
Disclosure of Unapproved or Investigational Use of a ProductAPA policy requires disclosure of unapproved or investigational uses of products discussed in CME programs. Off-label use of medications by individual physicians is permitted and common. Decisions about off-label use can be guided by the scientific literature and clinical experience. Off-label uses of commercial products or services are not discussed in this CME program.
Copyright 2003 American Psychiatric Association
Article
Tables
References
CME
text A A A
Abstract
The body of law applied to the practice of psychiatry does not differ from that of medicine in general. Nevertheless, the diagnosis, treatment, and management of patients with psychiatric disorders present not only unique clinical and ethical concerns but also unique legal considerations. For instance, determination of a patient’s competency, as well as the patient’s ability to manage his or her personal affairs, may be required to determine the patient’s mental capacity to make health care decisions. Currently, competency determinations are particularly relevant for patients with Alzheimer’s disease or dementia related to AIDS. Psychiatrists commonly face ethical and legal issues such as informed consent, the right to treatment, the right to refuse treatment, substitute decision making, and advance directives when treating psychiatric patients.Abstract Teaser
Figures in this Article

    Psychiatrists’ vulnerability to malpractice suits has increased, particularly in certain areas of psychiatric practice. Table 1+ summarizes the malpractice claims experience of the Professional Liability Insurance Program endorsed by the American Psychiatric Association (APA) (+1). Somatic therapies, assessment and management of violent patients, techniques to recover memories of sexual abuse, sexual misconduct, boundary violations, premature discharge of potentially violent patients, and managed care settings are areas of heightened liability for the psychiatric practitioner.
    The chances of a psychiatrist’s being sued in the 1980s were 1 in 25 per year (+1). By 1995, however, the odds had increased to about 1 of every 12 psychiatrists per year. In some states psychiatrists were sued at the rate of 1 in 6 per year. The APA Professional Liability Insurance Program identifies several factors to account for the increase in malpractice suits:
    With the advent of managed care, psychiatrists treat a large volume of patients for brief visits, creating greater liability exposure. With less time spent with a patient, the likelihood of developing a working alliance is reduced. Among primary care physicians, it has been reported that those who have had no malpractice claims against tended to use more statements of orientation, laughed more and used more humor, and engaged patients more in a give-and-take dialogue than did colleagues who had been sued (+2). They also spent more time in routine visits than did those who had been sued (mean, 18.3 vs. 15.0 minutes). The length of the visit was an independent factor in predicting claims status.
    Despite the increase in malpractice claims, psychiatrists prevail in seven out of every eight suits brought against them. The plaintiff has the heavy burden of proving his or her malpractice claim.
    Malpractice is the provision of substandard professional care that causes a compensable injury to a person with whom a professional relationship existed. Although this concept may seem relatively clear and simple, it has its share of conditions and caveats. For example, the essential issue is not the existence of substandard care per se, but whether there is compensable liability.
    KEY POINTS:
    Medical malpractice is a tort (i.e., a wrong that is noncriminal and not related to a contract). It is a type of civil wrong committed as a result of negligence by a physician that causes injury to a patient in his or her care. Negligence, the fundamental concept underlying a malpractice lawsuit, is simply described as either doing something that a physician with a duty of care (to the patient) should not have done or failing to do something that a physician with a duty of care should have done. The fact that a psychiatrist commits an act of negligence does not automatically make him or her liable to the patient who sues.
    For a psychiatrist to be found liable to a patient for malpractice, four fundamental elements (see Quick Reference Table 1+) must be established by a preponderance of the evidence, which essentially means "more likely than not": 1) that there was a duty of care owed by the defendant, 2) that the duty of care was breached, 3) that the plaintiff (i.e., the patient) suffered actual damages, and 4) that the deviation was the direct cause of the damages. Each of these four elements must be met, or there can be no finding of liability, regardless of any finding of negligence. A psychiatrist may be negligent but still not found to be liable. For example, if the patient suffered no real injuries because of the negligence, or if there was an injury but it was not directly caused by the psychiatrist’s negligence, a claim of malpractice will be defeated.
    Critical to establishing a claim of professional negligence is the requirement that the defendant’s conduct was substandard or was a deviation from the standard of care owed to the plaintiff. Except in the case of "specialists," the law presumes and holds all physicians to a standard of ordinary care, which is measured by its reasonableness according to the clinical circumstances in which it is provided.
    In terms of potential liability, the use of a somatic therapy, including electroconvulsive therapy (ECT), is evaluated no differently than the use of any other medical treatment or procedure. The same general standard of ordinary and reasonable care governs the assessment of whether a psychiatrist’s use of or failure to use a somatic intervention is legally actionable.
    It is generally acknowledged within the psychiatric profession that there is no absolute standard protocol for the administration of psychotropic medication or ECT. Nevertheless, the existence of professional treatment guidelines and procedures that are generally accepted or used by a significant number of psychiatrists should prompt clinicians to consider such guidelines as practice reference sources. For example, APA has published comprehensive findings and guidelines in the form of task force reports on ECT (+3) and tardive dyskinesia (+4). Nevertheless, official guidelines must not preempt sound professional judgment in attending to the specific clinical needs of patients.
    Published guidelines and procedures do not, per se, establish the standard of care by which a court might evaluate a psychiatrist’s treatment, but they do represent a credible source of information with which a reasonable psychiatrist should at least be familiar and should have considered (Stone v. Proctor 1963). In addition to expert testimony, courts generally consider official guidelines and the professional literature that establish contemporary psychiatric practices in determining the standard of care.
    There is less professional autonomy and flexibility associated with the use of ECT. Usually, the "reasonable care" standard applied to psychiatric treatment is construed in a fairly broad manner. However, some psychiatric treatments are more rigidly regulated than others. For instance, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) considers ECT a "special treatment" procedure, to be regulated by written policies. Whenever ECT is used, the procedure must be adequately justified and documented in the patient’s medical chart (+5). The ECT policies of treatment facilities as well as judicial decisions and statutory regulation of ECT can also serve as establishing the basis for liability, if violated. Malpractice suits involving ECT are infrequent.
    The standard for judging the use and administration of medication, on the other hand, appears to be consistent with the more flexible and general reasonable care requirement. Another reference source is the Physicians’ Desk Reference (PDR), which may be used to establish or dispute a psychiatrist’s pharmacotherapy procedures. The PDR is a commercially distributed and privately published reference of medication products used in the United States. The U.S. Food and Drug Administration (FDA) requires that drug manufacturers have their official package inserts reported in the PDR (+6). Accordingly, psychiatrists consult publications such as the PDR as needed for current and accurate medication information. Although numerous courts have cited the PDR as a credible source of medication-related information in the medical profession, the PDR does not by itself establish the standard of care. Rather, it may be used as one piece of evidence to establish the standard of care in a particular situation. Courts generally hold that drug inserts alone do not set the standard of care. They are only one element to be considered, along with previous clinical experience, the scientific literature, approvals in other countries, expert testimony, and other pertinent factors. The presence of a substantial scientific literature that justifies the clinician’s treatment is vastly more persuasive than FDA approval. The PDR or any other reference cannot serve as a substitute for the psychiatrist’s sound clinical judgment.
    Fortunately, courts recognize the importance of professional judgment and give psychiatrists, like other medical specialists, latitude in explaining special diagnostic or treatment considerations that guide their decision making. For instance, the clinical data regarding pharmacological treatment of rapid-cycling bipolar disorder indicate that a variety of potentially useful drug therapies exist, some of which are considered experimental or on the cutting edge (+7). Various drugs and hormones, for example, are clinically useful as mood stabilizers, such as carbamazepine, clozapine, thyroid and estrogen replacement therapy, calcium channel blockers, antihypertensives, neuroleptics, atypical antipsychotics, and other anticonvulsants (lamotrigine, valproate, and gabapentin).
    The courts consider that no one treatment of choice exists and that treatment applications are still being developed. Evidence that a treatment procedure is accepted by at least a respectable minority of professionals in the field can establish that a particular treatment is a reasonable professional practice (+8). The final word on treatment interventions is determined by the clinician and the clinical needs of the patient, not the law.
    Although no reliable compilation of malpractice claims data has been published, anecdotal information suggests that medication-related lawsuits constitute a significant share of the litigation filed against psychiatrists. As noted, claims data from the APA Professional Liability Insurance Program showed that medication error and drug reactions constituted 7% of malpractice allegations.
    +

    Evaluation

    Sound clinical practice requires that before any form of treatment is initiated, the patient should be properly evaluated. The nature and extent of an evaluation is largely dictated by the type of treatment being contemplated and the patient’s medical and psychiatric condition. A physical examination should be conducted or obtained if clinically indicated. A recently performed physical examination may suffice, or patients may be referred elsewhere if the psychiatrist does not perform physical examinations. Lawsuits have resulted from failure to evaluate a patient properly before administering medications.
    +

    Monitoring

    Probably the most common act of negligence associated with pharmacotherapy is the failure to monitor the patient while he or she is taking medication, including carefully following the patient for adverse side effects.
    Once psychotropic medication is prescribed, it is the psychiatrist’s duty to monitor the patient. Consultation or referral may be necessary according to the clinical needs of the patient. Monitoring may require the use of laboratory testing. Serum drug levels are obtainable for a number of psychotropic medications. The primary indications for laboratory tests include assessment of therapeutic and toxic levels of medication and of the patient’s adherence to the medication regimen. The use of carbamazepine, valproate, and clozapine requires periodic monitoring of the hematopoietic system and the liver. Failure to supervise patients to ensure that they are taking medications properly can delay or prevent the detection of harmful side effects and a change to more effective treatment. If a patient is harmed, a malpractice action may result.
    KEY POINTS:
    +

    Split treatment

    Split treatment situations require that the psychiatrist keep informed about the patient’s clinical status as well as about the nature and quality of treatment the patient is receiving from the nonmedical therapist (+9). In a collaborative relationship, responsibility for the patient’s care is shared according to the qualifications and limitations of each discipline. The responsibilities of each discipline do not diminish those of the other disciplines. Patients should be informed of the separate responsibilities of each discipline. Periodic evaluation by the psychiatrist and the nonmedical therapist of the patient’s clinical condition and needs is necessary to determine whether the collaboration should continue. On termination of the collaborative relationship, the patient should be informed in a clinically supportive manner. In split treatments, if negligence is claimed on the part of the nonmedical therapist, it is likely that the collaborating psychiatrist will be sued, and vice versa (+10).
    In managed care or similar treatment settings, the mere prescribing of medication without an informed working relationship between patient and physician does not meet generally accepted standards of good clinical care. Fragmented care, in which the psychiatrist functions only as a prescriber of medication while remaining uninformed about the patient’s overall clinical status, constitutes substandard treatment that may lead to a malpractice action. Such a practice may diminish the efficacy of the drug treatment itself or even lead to the patient’s failure to take the prescribed medication.
    Psychiatrists who prescribe medication in split treatment arrangements should be able to hospitalize a patient if necessary. If the psychiatrist does not have admitting privileges, prearrangements should exist with other psychiatrists who can hospitalize a patient if an emergency arises.
    KEY POINTS:
    +

    Prescription practices

    The selection of a medication, determination of initial dosage and form of administration, and related procedures are all decisions left to the professional discretion of the treating psychiatrist. In managed care settings, psychiatrists should vigorously resist attempts to limit their choice of drugs by a restrictive or closed formulary or by therapeutic substitution (interchanging different chemical agents from the same therapeutic class, such as a tricyclic antidepressant substituted for a selective serotonin reuptake inhibitor). The prescribing of specific medications should be determined by the psychiatrist and the clinical needs of the patient. An appeal should be filed if a drug that is not formulary approved is denied. The law recognizes that the physician is in the best position to "know the patient" and to determine what course of treatment is best under the circumstances. The standard by which a psychiatrist’s prescription practices will be evaluated is that of reasonableness. In administering psychotropic medication, psychiatrists need only conform their procedures and decision making to those that are ordinarily practiced by other psychiatrists under similar circumstances.
    A review of cases involving allegations of negligent prescription procedures reveals several common practices that represent potential deviations from generally accepted treatment practice:
    A physician who prescribes medication has a duty to first obtain the informed consent of the patient (see Quick Reference Table 5+). Obtaining competent informed consent may be complicated by the fact that some psychiatric patients exhibit compromised mental capacity for health care decision making as a result of their mental illness. Patients lacking such decision-making capacity require consent for treatment by substitute decision makers (Table 2+).
    Whenever a medication is changed and a new drug is prescribed, informed consent should be obtained. Failure to inform a patient properly of the risks and benefits of a prescribed medication can be grounds for a malpractice action, if the patient is injured as a result.
    Other areas of negligence involving medication that have resulted in legal action include 1) failure to treat side effects after they have been recognized or should have been recognized, 2) failure to monitor a patient’s compliance with prescription limits, 3) failure to prescribe medication or appropriate levels of medication according to the patient’s treatment needs, 4) failure to refer a patient for consultation or treatment by a specialist, and 5) negligent withdrawal from medication and unclear or illegible medication orders or prescriptions.
    The development of neuroleptic medications in the mid-1950s dramatically improved the treatment and management of patients with schizophrenia. However, shortly after the introduction of neuroleptic medications as therapeutic agents, researchers and clinicians observed unusual muscle movements in some patients, referred to as tardive dyskinesia.
    The risk of developing tardive dyskinesia is estimated at 4%—7% per year of neuroleptic use. These projections are even higher for elderly patients. With the use of atypical antipsychotic drugs, the risk of developing tardive dyskinesia is expected to be lower. Despite the possibility of a large number of lawsuits related to tardive dyskinesia, relatively few psychiatrists have been sued.
    Allegations of negligence after a patient develops tardive dyskinesia are based on the same legal elements as any other malpractice action. The bases for negligence mirror those previously identified in general medication cases. These areas include but are not limited to:
    Patients receiving antipsychotic medications must be monitored with frequent evaluations. No stock answer can be given to the question of how frequently the psychiatrist should see a patient. Generally, psychiatrists should schedule return visits with a frequency that is in accord with the patient’s clinical need. However, the longer the time between visits, the greater the risk that the psychiatrist will miss adverse drug reactions and untoward developments in the patient’s condition. The interval between visits ordinarily should not exceed 6 months.
    The defenses and preventive measures applicable to malpractice claims related to tardive dyskinesia are consistent with those used in any case alleging negligent drug treatment. Sound clinical practice accompanied by the patient’s competent informed consent, appropriately documented in the medical chart, serves as an effective foil to any allegations of negligence should tardive dyskinesia develop.
    With the shortening of hospital lengths of stay in recent years, the use of ECT appears to be increasing. Legal actions alleging negligence associated with ECT are infrequent. Cases involving ECT-related injuries have included a variety of circumstances in which negligence has occurred. These cases can be categorized into three groups: pretreatment, treatment, and posttreatment.
    Pretreatment. Although pre-ECT evaluations vary somewhat, generally the following procedures, recommended by the APA Task Force on Electroconvulsive Therapy (+3), should be performed:
    1. A psychiatric history and examination to evaluate the indications for ECT
    2. A medical examination to determine risk factors
    3. Anesthesia evaluation
    4. Informed consent (written)
    5. An evaluation by a physician privileged to administer ECT
    Although these recommendations do not define in absolute terms the standard of care for ECT, they may be proffered as evidence of the standard of care in malpractice suits involving ECT. Official treatment guidelines, however, should not be a substitute for the psychiatrist’s sound clinical judgment. Nevertheless, failure to conduct appropriate pretreatment procedures could endanger the welfare of the patient and ultimately result in a lawsuit.
    Treatment. Lawsuits involving ECT-related injuries in which the negligence is related to the actual treatment process include the following errors:
    Posttreatment. It is common for patients treated with ECT to experience side effects such as temporary confusion, disorientation, and memory loss immediately after treatment. Because of these temporary debilitating effects, sound clinical practice requires that psychiatrists provide reasonable posttreatment care and safeguards. Courts have held that the failure to attend properly to a patient for a period of time after administering ECT can result in malpractice liability. The following are examples of posttreatment circumstances that may constitute a basis for a lawsuit:
    As a source of civil liability, ECT-related lawsuits today are infrequent and are not likely to represent a significant malpractice risk for psychiatrists.
    Buttressed by constitutionally derived rights to privacy and freedom from cruel and unusual punishment, the common law tort of battery, and the doctrine of informed consent, mentally disabled persons are increasingly being afforded protections traditionally reserved for the legally competent. This new freedom often runs counter to the dictates of clinical judgment (i.e., to treat and protect). As a result of this conflict, the courts vary considerably on the parameters of this right and the procedures to be followed.
    KEY POINTS:
    Two landmark cases illustrate this point. In Rennie v. Klein (1978), the Third Circuit Court of Appeals recognized a right to refuse treatment in the state of New Jersey. The court, after extended litigation, found that this right could be overridden and antipsychotic drugs administered "whenever, in the exercise of professional judgment, such an action is deemed necessary to prevent the patient from endangering himself or others." In a Massachusetts case, Rogers v. Commissioner of Department of Mental Health (1983), the court decided that in the absence of an emergency (e.g., serious threat of extreme violence or personal injury), any person who has not been adjudicated incompetent has a right to refuse antipsychotic medication. Incompetent persons have a similar right, but it must be exercised through a "substituted judgment treatment plan" that has been reviewed and approved by the court.
    These two decisions are often viewed as legal bookends to the issue of the right to refuse treatment. The cases suggest parameters for other courts attempting to define such a right. The Rennie case became the model for subsequent legal decisions that adopted a treatment-driven rationale for the right to refuse treatment. Rogers became the basis for rights-driven approaches taken by some courts in litigating the right to refuse treatment.
    Numerous state and federal decisions have tackled some aspect of this issue. Generally speaking, there is near-judicial recognition of an involuntarily hospitalized patient’s right to refuse medication absent an emergency. Case law criteria for emergencies range from a risk of imminent harm to self or others to a deterioration in the patient’s mental condition if treatment is halted. Until either more states enact legislation or the U.S. Supreme Court rules squarely on this issue, jurisdictions will continue to vary on the substance of the right to refuse treatment and the procedures by which such a right can be implemented.
    The most common legal action involving psychiatric care is the failure to provide reasonable protection to patients from harming themselves. Theories of negligence involving suicide can be grouped into three broad categories: failure to diagnose properly, that is, to assess the potential for suicide; failure to treat, that is, to use reasonable treatment interventions and precautions; and failure to implement, that is, to carry out treatment properly and not negligently.
    These theories, each of which applies to inpatient and outpatient settings, are based on the practitioner’s failure to act reasonably in exercising the appropriate duty of care owed to the patient. Wrongful death suits as a result of patient suicides are based on the legal concepts of foreseeability, reasonableness, and causation. A typical lawsuit argues that a patient with the potential for suicide was not diagnosed and treated properly, resulting in the patient’s death.
    As a general rule, a psychiatrist who exercises reasonable care in compliance with accepted medical practice will not be held liable for any resulting injury. Normally, if a patient’s suicide was not reasonably foreseeable, or if the suicide occurred as a result of intervening factors, this rule will apply.
    +

    Foreseeable suicide

    The evaluation of suicide risk is one of the most complex, difficult, and challenging clinical tasks in psychiatry. A comprehensive assessment of a patient’s suicide risk is critical to a sound clinical management plan. Using reasonable care in assessing suicide risk can preempt the problem of predicting the actual occurrence of suicide, for which professional standards have not yet been developed. The risk of suicide is foreseeable, but not the prediction of who will commit suicide. Standard approaches to the assessment of suicide risk are described in the psychiatric literature (+11—+14). Short-term suicide risk assessments are more reliable than long-term assessments. Time attenuates suicide risk assessments, requiring that assessment be a process, not an event.
    As an accepted standard of care, an evaluation of suicide risk should be done with all patients, regardless of whether they present with overt suicidal complaints. A review of case law shows that reasonable care requires that a patient who is either suspected of being or confirmed to be suicidal must be the subject of certain affirmative precautions. A failure either to assess reasonably a patient’s suicide risk or to implement an appropriate precautionary plan after the suicide risk becomes foreseeable is likely to render a practitioner liable if the patient is harmed because of a suicide attempt. The law tends to assume that suicide is preventable if it is foreseeable. Foreseeability, however, should not be confused with preventability. In hindsight, many suicides seem preventable that were clearly not foreseeable.
    When suicide risk assessments are competently performed and recorded, the psychiatrist demonstrates that he or she was careful and thorough in the management of the suicidal patient. Moreover, evidence of a reasonable suicide risk assessment also demonstrates that the psychiatrist adhered to the prevailing standard of care. Although psychiatrists cannot ensure favorable outcomes with suicidal patients, they can ensure that the process of suicide risk assessment was competently performed (+15).
    +

    Inpatients

    Intervention in an inpatient setting usually requires the following:
    Careful documentation of assessments and of management interventions that remain responsive to the patient’s clinical situation should be considered evidence of clinically and legally sufficient psychiatric care. Systematic suicide risk assessment is essential. Documenting the benefits of a psychiatric intervention (e.g., ward change, pass, and discharge) against the risk of suicide permits an evenhanded approach to the clinical management of the patient. Systematic suicide risk assessment evaluates both risk and protective factors. Consideration only of a patient’s suicide risk is a manifestation of defensive psychiatry that usually interferes with good clinical care, further exposing the psychiatrist to malpractice liability.
    Psychiatrists are more likely to be sued when a psychiatric inpatient commits suicide. The law presumes that the opportunities to foresee (i.e., anticipate) and control (i.e., treat and manage) suicidal patients are greater in the hospital setting.
    +

    Outpatients

    Psychiatrists are expected to reasonably assess the patient’s risk of suicide. The result of the assessment dictates the duty-of-care options. Courts have reasoned that when an outpatient commits suicide, the therapist has not necessarily breached a duty to safeguard the patient from foreseeable self-harm because of the difficulty in controlling the patient. Instead, the reasonableness of the psychiatrist’s assessment, treatment, and management is determinative.
    +

    Suicide prevention pacts

    Suicide prevention contracts created between the clinician and the patient attempt to develop an expressed understanding that the patient will call for help rather than act out suicidal thoughts or impulses. These contracts have no legal authority. Although they may be helpful in solidifying the therapeutic alliance, they may falsely reassure the psychiatrist. Suicide prevention agreements between psychiatrists and patients must not be used in place of adequate suicide assessment (+16). There is no evidence that suicide prevention contracts decrease the risk of suicide.
    KEY POINTS:
    +

    Legal defenses

    One legal defense that has created a split in the courts involves the use of the "open-door" policy, in which patients are allowed freedom of movement for therapeutic purposes. The individual facts of the case and reasonableness of the staff’s application of the open-door policy appear to be paramount. Nevertheless, courts have difficulty with abstract treatment notions such as personal growth when faced with a dead patient.
    Another defense, the doctrine of sovereign or governmental immunity, may by statute bar a finding of liability against a state or federal facility. An intervening cause of suicide over which the clinician had no control is another valid legal defense. For example, a court may find a psychiatrist not liable for the suicidal act of a patient with borderline personality disorder who experienced a significant rejection between therapy sessions and then impulsively attempted suicide, without trying to contact the psychiatrist. The court may rule that the suicide was caused by the superseding intervening variable of an unforeseen rejection and not by the psychiatrist’s negligence. Finally, the best-judgment defense has been used successfully when the patient was properly assessed and treated for suicide risk but he or she committed suicide anyway (+17).
    As a general rule, one person has no duty to control the conduct of a second person to prevent that person from physically harming a third person. Applying this rule to psychiatric care, psychiatrists traditionally have had only a limited duty to control hospitalized patients and to exercise due care on discharge. After the Tarasoff ruling, the therapist’s legal duty and potential liability significantly expanded. In Tarasoff, the California Supreme Court first recognized that a duty to protect third parties was imposed only when a special relationship existed between the victim, the individual whose conduct created the danger, and the defendant. The court stated that "the single relationship of a doctor to his patient is sufficient to support the duty to exercise reasonable care to protect others" from the violent acts of patients.
    KEY POINTS:
    Psychiatrists do not have the ability to predict violence with any accuracy. Violent behaviors are the result of the complex interplay among social, clinical, and personality factors that vary significantly across situations and time (+18). Nonetheless, clinical methods for assessing the risk of violence are available that reflect the current standard of care (+6, +19—+21).
    The MacArthur Violence Risk Assessment Study (+22) was established to improve clinical risk assessment validity, to enhance effective clinical risk management, and to provide data on mental disorders and violence for informing mental health law and policy. The study found that the validity of violence risk assessments is modestly better than chance. Until more studies are available, sound clinical practice requires that thorough violence risk assessments be routinely performed on potentially violent patients on the basis of current knowledge of violence risk factors. In inpatient settings, violence risk assessments need to be made at such critical points as the initiation of ward status changes, passes, and discharge. Violence risk assessment is more of a continuing process than a solitary event. All such assessments should be duly recorded.
    The index of suspicion for potential violence should be high for patients with a past history of violence who are making current, serious threats of harm toward specific individuals. The potential for violence is further heightened if the patient is acutely psychotic, substance abusing, angry, fearful of being harmed, and experiencing delusions of being controlled or influenced (+23).
    After the Tarasoff ruling, courts in other jurisdictions have interpreted the case variously. Some states have adopted the Tarasoff holding, whereas others have limited or extended its scope and reach. In most states, psychotherapists have a duty, established by case law or statute, to act affirmatively to protect an endangered third party from a patient’s violent or dangerous acts. A few courts have declined to find a Tarasoff duty in a specific case, whereas some courts have simply rejected the Tarasoff duty. The Texas Supreme Court ruled that the state statute permits but does not require disclosures by therapists of threats of harm to third parties by their patients.
    Most courts have found no duty to protect without an imminent threat of serious harm to a foreseeable victim. Only a small minority of courts have held that a duty to protect exists for the population at large. In some jurisdictions, courts have held that the need to safeguard the public well-being overrides all other considerations, including confidentiality. Although a few courts have declined to find a Tarasoff duty in a specific case, a growing number of courts have recognized some variation of the original Tarasoff duty. Despite the fact that the Tarasoff duty is still not law in some jurisdictions and is subject to different interpretations by individual courts, clinicians should consider the duty to protect to be a national standard of practice.
    Several states have enacted immunity statutes that protect the psychiatrist from legal liability caused by a patient’s violent acts toward others (+24). Most of these statutes define the therapist’s duty in terms of warning the endangered third party or notifying the authorities. The duty-to-protect language used in some statutes allows for a greater variety of clinical interventions.
    +

    Evolving trends

    An important evolving trend is the application of the Tarasoff duty to sexual abuse cases by an alleged pedophile. A psychiatrist who knew that one of his patients, a psychiatric resident, was a pedophile was successfully sued for not reporting that fact to the medical school at which the resident was training. The resident molested a child at a hospital crisis center. The court reasoned that the defendant’s control over the psychiatric resident was far greater than in the typical psychiatrist-patient relationship. A Tarasoff duty was also found where a spouse had knowledge of her husband’s sexually abusive behavior against children in the neighborhood. In another case, the court found that a Tarasoff duty could exist but declined to find the parents of a babysitter liable for his dangerous sexual behavior. The court determined that no evidence existed that the parents knew of their son’s proclivity to commit a sexual assault.
    +

    Release of potentially violent patients

    Under managed care, discharging violent or potentially violent inpatients presents unique challenges for treating psychiatrists (+25). The treatment of psychiatric inpatients has changed dramatically in the managed care era (+26). Most psychiatric units, particularly in general hospitals, have become short-stay acute-care psychiatric facilities. Generally, only suicidal, homicidal, or gravely disabled patients with major psychiatric disorders pass strict precertification review for hospitalization (+27). Close scrutiny by utilization reviewers permits only brief hospitalization for such patients (+28). The purpose of hospitalization is crisis intervention and management to stabilize patients and to ensure their safety. Although treatment for these patients is provided by a variety of mental health professionals, the psychiatrist usually must bear the ultimate burden of liability for treatments gone awry (+29). Usually the prospects are limited for psychiatrists to develop a therapeutic alliance with patients during the hospital stay. Opportunities to communicate with patients, the psychiatrist’s stock-in-trade, are often severely curtailed. All these factors contribute to a greatly increased risk of malpractice suits against psychiatrists alleging premature or negligent discharge of patients due to cost-containment policies.
    More control can be maintained over the patient in the hospital setting than in outpatient treatment. Courts closely evaluate decisions made by psychiatrists treating inpatients that adversely affect the patient or a third party. Liability imposed on psychiatric facilities that had custody of patients who injured others outside the institution after escape or release is clearly distinguishable from the factual situation of Tarasoff. Duty-to-warn cases generally involve patients in outpatient treatment. Liability arises from the inaction of the therapist, who fails to take affirmative measures to warn or protect endangered third parties. In negligent-release cases, liability may arise from the allegation that the institution’s affirmative act in releasing the patient caused injury to the third party. Nonetheless, allegations may be made that a psychiatrist or hospital personnel failed, prior to the patient’s discharge, to warn individuals known to be at risk of harm from that patient. Lawsuits stemming from the release of foreseeably dangerous patients who subsequently injure or kill others are roughly five to six times more common than outpatient duty-to-warn litigation (+30).
    The psychiatrist’s liability is determined by reference to professional standards. Consultation with other psychiatrists may provide additional protection when the discharge of a potentially violent patient appears problematic. Consulting with an attorney may help clarify legal obligations. However, lawyers tend to be highly risk averse and conservative when making recommendations. Sound legal advice may not necessarily accord with the clinical realities of the management of a specific patient. Clinicians must continue to exercise their professional judgment.
    The patient’s willingness to cooperate with the psychiatrist is critical to maintaining follow-up treatment. The psychiatrist’s obligation focuses on structuring the follow-up visits in such a manner as to encourage compliance. A study of Veterans Administration (VA) inpatient referrals to a VA mental health outpatient clinic showed that of 24% of inpatients referred, approximately one-half failed to keep their first appointments (+31). Nevertheless, there are limitations on the extent of the psychiatrist’s ability to ensure follow-up care. Most patients retain the right to refuse treatment. These limitations must be acknowledged by both the psychiatric and legal communities (+6). The American Medical Association Council on Scientific Affairs has developed evidence-based discharge criteria for safe discharge from the hospital (+32).
    In either the outpatient or inpatient situation, psychiatrists are in compliance with the responsibility to warn and protect others from potentially violent patients if they reasonably assess a patient’s risk for violence and make clinically appropriate interventions on the basis of their findings. Although professional standards exist for assessment of the risk factors for violence (+33), no standard of care has been established for the prediction of violent behavior. The clinician should assess the risk of violence frequently, updating the risk assessment at significant clinical junctures (e.g., room and ward changes, passes, and discharge). A risk-benefit assessment should be conducted and recorded before a pass or discharge is issued. Assessing the risk of violence is a "here and now" determination performed at the time of discharge. After the patient is discharged, the potential for violence against self or others depends on the nature and course of the mental illness, adequacy of treatment after discharge, adherence to treatment recommendations, and exposure to unforeseeable stressful life events.
    KEY POINTS:
    A person may be involuntarily hospitalized only if certain statutorily mandated criteria are met. Three main substantive criteria serve as the foundation for all statutory commitment requirements: the individual must 1) be mentally ill, 2) be dangerous to self or others, and/or 3) be unable to provide for his or her basic needs. Generally, each state spells out which criteria are required and what each means. Terms such as "mentally ill" are often loosely described, thus leaving the responsibility for proper definition to the clinical judgment of the petitioner.
    In addition to individuals with mental illness, certain states have enacted legislation that permits involuntary hospitalization of three other distinct groups: persons with developmental disabilities (mental retardation), persons with substance (alcohol or drugs) addiction, and minors with mental disabilities. Special commitment provisions as well as various due process rights may govern requirements for the admission and discharge of mentally disabled minors.
    Involuntary hospitalization of psychiatric patients usually occurs when violent behavior threatens to erupt toward the self or others and when patients become unable to care for themselves. Such patients frequently manifest mental disorders and conditions that readily meet the substantive criteria for involuntary hospitalization.
    Clinicians do not commit patients. Commitment is solely under the jurisdiction of the court. The psychiatrist merely initiates a medical certification that brings the patient before the court, usually after a brief period of hospitalization for evaluation. In seeking medical certification, the psychiatrist must be guided by the treatment needs of the patient. Clinicians should not attempt to second-guess the court’s ultimate decision about involuntary hospitalization.
    Commitment statutes do not require involuntary hospitalization but are permissive (+24). The statutes enable mental health professionals and others to seek involuntary hospitalization for persons who meet certain substantive criteria. On the other hand, the duty to seek involuntary hospitalization is a standard-of-care issue. Patients who are mentally ill and pose an imminent, serious threat to themselves or others may require involuntary hospitalization as a primary psychiatric intervention.
    KEY POINTS:
    +

    Liability

    The most common cause of a malpractice action involving involuntary hospitalization is the failure of a psychiatrist to adhere in good faith to statutory requirements, leading to a wrongful commitment. Often these lawsuits are brought under the theory of false imprisonment. Other areas of liability that may arise from wrongful commitment include assault and battery, malicious prosecution, abuse of authority, and intentional infliction of emotional distress (+6).
    In many states, psychiatrists are granted immunity from liability as long as they use reasonable professional judgment and act in good faith when petitioning for commitment (+34). Performing a careful examination of the patient, abiding by the requirements of the law, and ensuring that sound reasoning motivates the certification of the patient are good clinical practice and, secondarily, good risk management. Evidences of willful, blatant, or gross failure to adhere to statutorily defined commitment procedures may expose a psychiatrist to a lawsuit.
    +

    Rights of involuntarily hospitalized patients

    Most states recognize the right of inpatients to refuse treatment. Even though a patient may be involuntarily hospitalized, that hospitalization does not negate a presumption of competence. In most states, involuntarily hospitalized patients who refuse medication require a separate court hearing for an adjudication of incompetence and the provision of substituted consent by the court. Recently, persons hospitalized under criminal commitment have been accorded the right to refuse treatment. The courts have found that incarcerated patients’ constitutional right to due process is adequately protected by the exercise of professional judgment within the medical peer review process of the institution.
    Hospitalized patients possess other rights. Patients possess rights of visitation, for example, although these rights can be temporarily suspended for proper cause related to a patient’s care and treatment. Free communications of hospitalized patients through mail, telephone, and visitors are considered a right, unless protection of the patient or others requires supervision of communications. The right to privacy includes allowing patients to have secure locker space, private toilet and shower facilities, and a minimum square footage of floor space. Protection of confidentiality is also included. Economic rights include the right to have and spend money and to handle one’s own financial affairs responsibly. In most jurisdictions, involuntarily hospitalized patients do not lose their civil rights, such as the right to manage their own money. Hospitalized patients must be paid for their work in certain jurisdictions unless it is truly therapeutic labor (i.e., work not connected with maintenance of the hospital). "Patients’ rights" are not absolute and often must be tempered by the clinical judgment of the mental health professional. Inevitably, disputes over perceived or real violations of patients’ rights arise. In some jurisdictions, statutes require that a civil rights officer or ombudsman mediate such disputes.
    Patients who allege recovered memories of abuse have sued parents and other alleged perpetrators. In a turnabout, the alleged victimizers have sued therapists whom they claim negligently induced false memories of sexual abuse. In some cases, patients have recanted and joined forces with others (usually their parents) to sue their therapists.
    KEY POINTS:
    The debate on recovered memory has polarized many therapists into believers and disbelievers. Most therapists hold personal beliefs about the validity of recovered memories of sexual abuse that are somewhere between the extremes. Strongly held personal biases about recovered memories represent an occupational hazard for clinicians that can undermine the therapist’s duty of neutrality to patients, creating deviant treatment boundaries and increasing the risk of incurring liability.
    The basic allegation in such cases is that the therapist abandoned a position of neutrality to suggest, persuade, coerce, and implant false memories of childhood sexual abuse. The guiding principle of clinical risk management in recovered memory cases is for the therapist to maintain neutrality and establish sound treatment boundaries.
    Complicating the situation is the empirical evidence about memory mechanisms. As is typical for any emerging science, contradictory findings have been reported about how and what persons in various settings retain in memory and forget. Empirical studies frequently fail to distinguish whether allegedly repressed memories are not retrieved or simply not reported to researchers.
    Sound risk management rests solidly on a clinical footing and is secondarily informed by awareness of the pertinent legal issues (+35). Risk management principles that should be considered when evaluating or treating a patient who recovers memories of abuse while in psychotherapy include the following:
    Therapist-patient sex is invariably preceded by progressive boundary violations in treatment (+36). As a consequence, patients are frequently psychologically damaged by the precursor boundary violations as well as the eventual sexual misconduct of the therapist (+37). An excellent account of the gradual erosion of treatment boundaries leading to near loss of control with a client is given by Rutter (+38).
    General boundary guidelines exist for conducting psychiatric treatment (+39). Awareness of these guidelines and of their transgression may help alert the therapist to progressive boundary violations (+40). Sexual misconduct does not occur in isolation but usually involves a variety of negligent acts of omission and commission.
    KEY POINTS:
    +

    Civil liability

    Psychiatrists who sexually exploit their patients are subject to civil and criminal actions as well as ethical and professional licensure revocation proceedings. The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry (+41) states that sex with a current or former patient is unethical (section 2, annotation 1). Malpractice is the most common legal liability.
    In a sexual exploitation case, the plaintiff has the difficult burden of proving, by a preponderance of the evidence (i.e., "more likely than not"), that the exploitation actually took place. This burden can be met when the plaintiff provides corroborating evidence to support the claim, such as testimony from other abused (former) patients, letters, pictures, hotel or motel receipts, and identification of incriminating body markings of the exploiter. If the defendant practitioner admits to the exploitation, the plaintiff is left with the responsibility of showing that he or she sustained injuries as a result of the sexual activity. Typically, patient injury occurs in the form of emotional injury (e.g., worsened psychiatric condition, suicide attempts, and hospitalization). Expert psychiatric testimony is usually required to establish the type and extent of psychological damages as well as to establish whether a breach of the standard of care occurred.
    An increasing number of states have made sexual activity with patients both civilly and criminally actionable by statute. For instance, Minnesota enacted legislation that states the following: "A cause of action against a psychotherapist for sexual exploitation exists for a patient or former patient for injury caused by sexual contact with the psychotherapist if the sexual contact occurred: 1) during the period the patient was receiving psychotherapy . . . or 2) after the period the patient received psychotherapy . . . if a) the former patient was emotionally dependent on the psychotherapist; or b) the sexual contact occurred by means of therapeutic deception."
    A few states have enacted civil statutes proscribing sexual misconduct (+6). Several states make therapist sexual misconduct a crime (+42). Some states prosecute sexual exploitation suits using their sexual assault statutes. Legislatures in a number of states have enacted statutes that provide civil or criminal remedies to patients who were sexually abused by their therapists (+43, +44).
    Three types of remedies have been codified: reporting, civil liability, and criminal prosecution. Reporting statutes require a therapist who learns of any past or current therapist-patient sex to disclose this information. A few states have civil statutes proscribing sexual misconduct (+42). Civil statutes incorporate a standard of care and make malpractice suits easier to pursue. For example, Minnesota’s statute provides a specific cause of action against psychiatrists and other psychotherapists for injury caused by sexual contact with a patient. Some of these statutes also restrict unfettered discovery of the plaintiff’s past sexual history. Criminal sanctions may be the only remedy for exploitative therapists without malpractice insurance, therapists who are unlicensed, or therapists who do not belong to professional organizations.
    Various causes of action may be asserted by a plaintiff who has been sexually exploited by a psychotherapist. In a minority of states, spouses of the injured patient also have legal standing to initiate their own cause of action against an exploitative practitioner on the grounds of loss of consortium (i.e., interference with the marital relationship).
    A variety of defenses have been raised to diminish or protect against liability, but to date, few have been legally successful (Table 5+). For instance, the contention that the patient was aware that sex was not a part of treatment, that the sex occurred outside the treatment setting, that treatment ended before the sexual relationship began, or that the patient consented to the sexual contact have all been rejected by the courts. Patients cannot consent to malpractice. In sexual misconduct cases, the issue is never the patient’s consent but always breach of fiduciary trust by the therapist.
    There is no "respected minority" in the profession that claims that sexual relations with patients is therapeutic. This position had a few adherents at one time but is no longer publicly advocated by credible mental health professionals.
    +

    Criminal sanctions

    Sexual exploitation of a patient, under certain circumstances, may be considered rape or some analogous sexual offense and may therefore be criminally actionable (+45). Typically, the criminality of the exploitation is determined by one of three factors: the practitioner’s means of inducement, the age of the victim, or the availability of a relevant state criminal code.
    Sex with a current patient may be criminally actionable under sexual assault statutes if the state can prove beyond a reasonable doubt (i.e., with 90%—95% certainty) that the patient was coerced into engaging in the sexual act. Typically, this type of evidence is limited to the use of some form of substance (e.g., medication) either to induce compliance or to reduce resistance. Anesthesia, ECT, hypnosis, drugs, force, and threat of harm have been used to coerce patients into sexual submission (+46). To date, claims of psychological coercion through the manipulation of transference phenomena have not been successful in establishing the coercion necessary for a criminal case. In cases involving a minor patient, the issue of consent or coercion is irrelevant because minors and adult incompetent persons are considered unable to provide valid consent. Therefore, sex with a child or an incompetent person is automatically considered a criminal act.
    +

    Professional disciplinary action

    For the purposes of adjudicating allegations of professional misconduct, licensing boards are typically granted certain regulatory and disciplinary authority by state statutes. As a result, state licensing organizations, unlike professional associations, may discipline an offending professional more effectively and punitively by suspending or revoking his or her license. Because licensing boards are not as restrained by rigorous rules of evidence in trial procedures as the courts are in civil and criminal actions, it is generally easier for the patient to seek redress through this means. Moreover, no time limitations exist for bringing charges. A review of published reports of sexual misconduct cases adjudicated before licensing boards revealed that in a vast majority of cases, the evidence was reasonably sufficient to substantiate a claim of exploitation, leading to revocation of the professional’s license or suspension from practice for varying lengths of time, including permanent suspension.
    Patients can bring ethical charges against psychiatrists before the district branches of APA. Ethical violators may be reprimanded, suspended, or expelled from APA. All national organizations of mental health professionals have ethically proscribed sexual relations between therapist and patient. Ethical charges can be filed only against members of a professional group; therefore, this option is not available to patients whose therapists do not belong to a professional organization.
    Confidentiality refers to the right of a patient to have communications spoken or written in confidence undisclosed to outside parties without implied or expressed authorization. Privilege, or more accurately testimonial privilege, can be viewed as a derivation of the right of confidentiality. Testimonial privilege is a statutorily created rule of evidence that permits the holder of the privilege (e.g., the patient) to exercise the right to prevent the person to whom confidential information was given (e.g., the psychiatrist) from disclosing it in a judicial proceeding.
    +

    Confidentiality

    Clinical-legal foundation. The basis for recognizing and safeguarding patient confidences is derived from four general sources. First, states have acknowledged this right of protection by including confidentiality provisions in either professional licensure laws or confidentiality and privilege statutes. The second source, and probably the most traditional, comprises the ethical codes of the various mental health professions. Third, the common law recognizes an attorney-client privilege, but developing case law has also carved out this source of protection for physicians and psychotherapists. In 1996, the U.S. Supreme Court ruled that communications between psychotherapist and patient are confidential and need not be disclosed in federal trials. Fourth, the right of confidentiality may be subsumed under the right of privacy.
    Breaching confidentiality. Regardless of the basis of the right of confidentiality, once the physician-patient relationship has been created, the professional assumes an automatic duty to safeguard a patient’s disclosures. This duty is not absolute, and there are circumstances in which breaching confidentiality is both ethical and legal.
    Patients waive confidentiality in a variety of situations, especially in managed care settings. Medical records are regularly sent to potential employers or to insurance companies when benefits are requested. A limited waiver of confidentiality ordinarily exists when a patient participates in group therapy. Whether one group member can be compelled in court to disclose information shared by another group member during group therapy has not been settled legally (+47). Many state confidentiality statutes provide exceptions to confidentiality between the psychiatrist and the patient in one or more situations (+48) (Table 6).
    Patients’ access to their own records is normally controlled by statutes. These statutory provisions are found under the heading of "medical records" or the much broader term "privilege."
    If a patient gives the psychiatrist good reason to believe that a warning should be issued to an endangered third party, the confidentiality of the communication that gave rise to the warning may be lost. Psychiatrists who have issued warnings have been compelled to testify in criminal cases (+49).
    KEY POINTS:
    +

    Testimonial privilege

    The patient—not the psychiatrist—is the holder of the privilege that controls the release of confidential information. Because the privilege applies only to the judicial setting, it is called testimonial privilege. Privilege statutes represent the most common recognition by the state of the importance of protecting information provided by a patient to a psychotherapist. This recognition moves away from the essential purpose of the American system of justice (e.g., "truth finding") by insulating certain information from disclosure in court. This protection is justified on the basis that the special need for privacy in the physician-patient relationship outweighs the unbridled quest for an accurate outcome in court.
    Privilege statutes usually are drafted with reference to one of the following four relationships, depending on the type of practitioner:
    Cases have been successfully litigated in which the broader physician-patient category has been applied to the psychotherapist when an applicable statute did not exist.
    Privilege statutes also specify exceptions to testimonial privilege. Although exceptions vary, the most common include the following:
    The last exception, known as the patient-litigant exception, commonly occurs in will contests, workers’ compensation cases, child custody disputes, personal injury actions, and malpractice actions in which the therapist is sued by the patient.
    +

    Liability

    An unauthorized or unwarranted breach of confidentiality can cause a patient considerable emotional harm. As a result, a psychiatrist typically can be held liable for such a breach on the basis of at least four theories:
    Informed consent is a legal theory in medical malpractice. It provides a patient with a cause of action for not being adequately informed about the nature and consequences of a particular medical treatment or procedure undertaken. This theory is founded on two distinct legal principles. The first is the right of every patient to determine what will or will not be done to his or her body, often referred to as the right of self-determination. The second principle emanates from the fiduciary nature of the physician-patient relationship. Inherent in a physician’s duty of fiduciary care is the responsibility to disclose honestly and in good faith all requisite facts concerning a patient’s condition. Included among factors to be disclosed are any treatment risks, alternatives, and consequences. The primary purpose of the doctrine of informed consent is to promote individual autonomy; secondarily, it is intended to promote rational decision making (+50).
    There are three essential elements to the doctrine of informed consent:
    Usually clinicians provide the first level of screening in identifying patient competency and in deciding whether to accept a patient’s treatment decision. The patient or a bona fide representative must be given an adequate description of the treatment. If the patient who refuses treatment appears to lack health care decision-making capacity, it does not mean that the patient cannot be treated. An appropriate substitute decision maker can provide (or withhold) consent. To be able to provide informed consent, the patient or substitute decision maker should be told about the risks, benefits, and prognosis both with and without treatment, as well as alternative treatments and their risks and benefits. In addition, the competent patient must voluntarily consent to or refuse the proposed treatment or procedure.
    The legal doctrine of informed consent is consistent with the provision of good clinical care. The informed consent doctrine allows patients to become partners in making treatment determinations that accord with their own needs and values. In the past, physicians operated under the "do no harm" principle. Today, psychiatrists are increasingly required to practice within the model of informed consent and patient autonomy. Most psychiatrists find increased patient autonomy desirable in fostering the development of the therapeutic alliance that is so essential to treatment. Furthermore, patient autonomy is the goal of most psychiatric treatments (+51).
    +

    Competency

    It is clinically useful to distinguish the terms incompetence and incapacity. Incompetence refers to a court adjudication, whereas incapacity indicates a functional inability as determined by a clinician (+34). Legally, only competent persons may give informed consent. An adult patient is considered legally competent unless adjudicated incompetent or temporarily incapacitated because of a medical emergency. Incapacity does not prevent treatment; it merely requires the clinician to obtain substitute consent. Treating an incompetent patient without substituted consent is the same as treating a competent patient against his or her will.
    KEY POINTS:
    Legal competence is narrowly defined as cognitive capacity. The definition derives largely from the laws governing transactions. Important clinical concepts such as affective incompetence are not usually recognized by the law unless cognitive capacity is significantly diminished. For example, a severely depressed but cognitively intact patient may refuse antidepressant medication owing to profound feelings of hopelessness, helplessness, and worthlessness. Manic patients emphasize risks of medications while downplaying benefits. Patients with schizophrenia tend to be fearful that medication will cause them serious harm. They are often unable to make a balanced assessment that considers both risks and benefits of a proposed drug. A study in which three instruments were used to assess competency for treatment decisions found that the schizophrenia and depression groups demonstrated poorer understanding of treatment disclosures, poorer reasoning in decision making regarding treatment, and a greater likelihood of failing to appreciate their illness or the potential treatment benefits (+52). Denial of illness often interferes with insight and the ability to appreciate the significance of information provided to the patient.
    Competency is not a scientifically determinable state and is situation specific. The issue of competency arises in a number of civil, criminal, and family law contexts. Although there are no hard-and-fast definitions, the patient’s ability to perform the following is legally germane to determining competency:
    This standard obtains only a simple consent from the patient rather than an informed consent, because alternative treatment choices are not addressed.
    A review of case law and scholarly literature reveals four standards for determining mental incapacity in decision making (+50). In order of increasing levels of mental capacity required, these standards are:
    Although some patients may communicate a choice and understand the information provided, they may lack the insight or ability to appreciate the information provided (+53). Rational decision making is impaired as well. For example, patients with schizophrenia tend to fear some idiosyncratic harm from the treatment while ignoring the actual risk of medication side effects.
    Psychiatrists generally feel most comfortable with a rational decision-making standard in determining patient incapacity for health care decision making. Most courts prefer the first two standards mentioned earlier but often combine competency standards. A truly informed consent that considers the patient’s autonomy, personal needs, and values occurs when rational decision making is applied by the patient to the risks and benefits of appropriate treatment options provided by the clinician.
    Grisso and Appelbaum (+52) found that the choice of standards determining competence affected the type and proportion of patients classified as impaired. When compound standards were used, the proportion of patients identified as impaired increased. These authors advised that clinicians be aware of the applicable standards in their jurisdictions.
    A valid consent can be either expressed (oral or in writing) or implied from the patient’s actions. The competency issue is particularly sensitive when dealing with minors or mentally disabled persons who lack the requisite cognitive capacity for health care decision making. In both cases, it is generally recognized in the law that an authorized representative or guardian may consent for the patient (see Table 4+).
    +

    Information

    The standard for exercising a legally sufficient disclosure varies from state to state. Traditionally, the duty to disclose was measured by a professional standard: either what a reasonable physician would disclose under the circumstances or the customary disclosure practices of physicians in a particular community. A patient-oriented standard now applies. This standard focuses on the "material" information that a reasonable person in the patient’s position would want to know to make a reasonably informed decision. An increasing number of courts have applied this standard, and some have expanded "material risks" to include information regarding the consequences of not consenting to the treatment or procedure. Even in patient-oriented jurisdictions, there is no duty to disclose every possible risk. A material risk is defined as one in which a physician knows or should know what would be considered significant by a reasonable person in the patient’s position. The issue of how much information a patient has to comprehend for consent to be valid is normally resolved by requiring a doctor to convey all appropriate information in terms that the average patient would understand.
    KEY POINTS:
    +

    Voluntariness

    For a consent to be considered legally voluntary, it must be given freely by the patient and without the presence of any form of coercion, fraud, or duress that impinges on the patient’s decision-making process. In evaluating whether a consent is truly voluntary, the courts typically examine all the relevant circumstances, including the psychiatrist’s manner, the environmental conditions, and the patient’s mental state.
    Malcolm (+54) noted the subtle differences in the concepts of coercion and persuasion. Persuasion is defined as the physician’s aim "to utilize the patient’s reasoning ability to arrive at a desired result." Coercion, by contrast, occurs "when the doctor aims to manipulate the patient by introducing extraneous elements which have the effect of undermining the patient’s ability to reason" (p. 241).
    +

    Exceptions and liability

    A second exception applies when a patient lacks sufficient mental capacity to give competent consent or is found to be legally incompetent. Someone who is incompetent is incapable of giving informed consent. Under these circumstances, consent must be obtained from a substitute decision maker.
    The third exception, therapeutic privilege, is the most difficult to apply. Informed consent may not be required if a psychiatrist determines that a complete disclosure of possible risks and alternatives might have a deleterious impact on the patient’s health and welfare. Jurisdictions vary in their application of this exception. Absent specific case law or statutes outlining the factors relevant to such a decision, a physician must substantiate a patient’s inability psychologically to withstand being informed of the proposed treatment. Some courts have held that therapeutic privilege may be invoked only if informing the patient will worsen his or her condition or so frighten the patient that rational decision making is precluded. Therapeutic privilege cannot be used as a means of circumventing the legal requirement for obtaining informed consent from the patient before initiating treatment.
    Finally, a physician need not disclose the risks of treatment when the patient has competently, knowingly, and voluntarily waived his or her right to be informed (e.g., when the patient does not want to be informed of drug risks).
    Absent a situation allowing one of the four exceptions, a psychiatrist who physically treats a patient without first obtaining informed consent is subject to legal liability. In some jurisdictions, a lack-of-informed-consent action may be defeated if case law or statute provides that a reasonable person under the given circumstances would have consented to treatment. As a rule of thumb, treatment given without any consent or against a patient’s wishes may constitute a battery (intentional tort), whereas treatment given with an inadequate consent will be treated as an act of medical negligence.
    The legal issues surrounding seclusion and restraint are complex. Seclusion and restraint have both indications and contraindications as clinical management tools (see Quick References Tables 6 and 7). The legal regulation of seclusion and restraint has become increasingly stringent over the past decade.
    Legal challenges to the use of restraints and seclusion have been made on behalf of the institutionalized mentally ill and the mentally retarded. Normally these lawsuits do not stand alone but are part of a challenge to a wide range of alleged abuses within a hospital.
    Generally courts hold, or consent decrees provide, that restraints and seclusion can be implemented only when a patient presents a risk of harm to self or others and no less restrictive alternative is available. Additional considerations include the following:
    1. Restraint and seclusion can be implemented only by a written order from an appropriate medical official.
    2. Orders are to be confined to specific, time-limited periods.
    3. A patient’s condition must be regularly reviewed and documented.
    4. Any extension of an original order must be reviewed and reauthorized.
    Most states have enacted statutes regulating the use of restraints, normally specifying the circumstances in which restraints can be used. Most often, those circumstances occur only when a risk of harm to self or others is imminent. Statutory regulation of the use of seclusion is far less common. Most states with laws regarding seclusion and restraint require some type of documentation of their use.
    A federal rule issued by the Health Care Financing Administration (HCFA) requires that hospital patients be seen face-to-face by a physician or a licensed independent practitioner (LIP) within 1 hour from the time a patient is restrained. An LIP is an individual who is recognized by both state law and hospital policy as having the independent authority to order restraints and seclusion for patients. This requirement is part of expanded policies regulating seclusion and restraint applicable to all hospitals receiving Medicare and Medicaid funds. The 1-hour requirement differs from the corresponding Joint Commission on Accreditation of Healthcare Organizations (JCAHO) mandate, which allows nurses to undertake evaluation and management tasks. The JCAHO standard also permits the physician or LIP to conduct an in-person evaluation of the patient within 4 hours of the initiation of restraint or seclusion for patients 18 years old or older. For patients under age 17, the in-person evaluation must be conducted within 2 hours of the initiation of restraint and seclusion. The 1-hour visit requirement by the HCFA is also recommended by the APA Task Force on the Psychiatric Uses of Seclusion and Restraint (+55). Regardless of their accreditation status, hospitals participating in Medicare or Medicaid must meet the standards in the Patient’s Rights Condition of Participation (+56). HCFA is working with JCAHO to ensure that the new Medicare requirements are incorporated into JCAHO standards.
    JCAHO made major revisions in its standards for the use of restraint and seclusion, effective January 2001, that seek to reduce the use of restraint and seclusion in order to provide greater assurance of safety and protection of patients with psychiatric or substance use disorders. The revised standards restrict the uses of restraints and seclusion to emergency situations in which there is imminent risk that the patient may inflict harm to self or others. Restraints are to be used only as a last resort. JCAHO has agreed to work with HCFA to enforce the 1-hour rule in hospitals receiving Medicare and Medicaid funds.
    On September 1, 1990, the National Practitioner Data Bank, established by the Health Care Quality Improvement Act of 1986, went into effect. The data bank tracks disciplinary actions, malpractice judgments, and settlements against physicians, dentists, and other health care professionals (+57).
    Hospitals, health maintenance organizations (HMOs), managed care organizations (MCOs), professional societies, state medical boards, and other health care organizations are required to report any disciplinary action taken against providers lasting more than 30 days. MCOs do not report physicians to the data bank if they do not follow treatment protocols. When a physician is deselected for a quality of care issue, the MCO must report it (+58). Disciplinary actions include limitation, suspension, or revocation of privileges or professional society membership. Medical malpractice payments account for about three-quarters of reports made to the data bank. Under the Health Care Quality Improvement Act, immunity from liability is granted to health care entities and providers that make peer review reports in good faith (+59).
    Hospitals are required to request information from the data bank concerning all physicians applying for staff privileges. Every 2 years, a query of the data bank is required concerning each physician or other practitioner on the hospital staff. Hospitals that do not comply face loss of immunity for professional peer review activities.
    The public does not have access to the data bank. Plaintiffs’ attorneys can have access to the data bank only if they can prove that the hospital failed to query the data bank about the physician in question. The information obtained can be used only to sue the hospital for negligent credentialing. Physicians can request information from the data bank about their own file. A recent study found that hospital reporting of actions taken regarding clinical privileges from 1991 to 1995 declined, raising concerns about underreporting (+60).
    KEY POINTS:
    Nearly every area of human endeavor is affected by the law and, as a fundamental condition, requires that one be mentally competent. Essentially, competency is defined as "having sufficient capacity, ability . . . [or] possessing the requisite physical, mental, natural, or legal qualifications" (61, p. 284). This definition is deliberately vague and ambiguous because competency is a broad concept encompassing many different legal issues and contexts. As a result, its definition, requirements, and application can vary widely, depending on the circumstances in which it is being measured (e.g., health care decisions, executing a will, and confessing to a crime).
    In general, competency refers to some minimal mental, cognitive, or behavioral ability, trait, or capability required to perform a particular legally recognized act or to assume some legal role. Incompetency is a judicial determination. The term incapacity, which is often interchanged with incompetency, refers to an individual’s functional inability to understand or to form an intention with regard to some act as determined by health care providers (+34).
    The legal designation of "incompetent" is applied to an individual who fails one of the mental tests of capacity and is therefore considered, by law, not to be mentally capable of performing a particular act or assuming a particular role. The adjudication of incompetence by a court is subject or issue specific. For example, the fact that a psychiatric patient is adjudicated incompetent to execute a will does not automatically render that patient incompetent to do other things, such as consent to treatment, testify as a witness, marry, drive, or make a legally binding contract.
    Generally, the law recognizes only the decisions or choices that have been made by a competent individual. The law seeks to protect incompetent individuals from the harmful effects of their acts. Persons over the age of majority, which is now 18, are presumed to be competent (+62). This presumption, however, is rebuttable by evidence of an individual’s incapacity. For the psychiatric patient, perception, short-term and long-term memory, judgment, language comprehension, verbal fluency, and reality orientation are mental functions that a court will scrutinize in questions of capacity and competency.
    The issue of competency, whether in a civil or criminal context, is commonly raised in two situations: when the person is a minor and when he or she is mentally disabled. In many situations, minors are not considered legally competent and therefore require the consent of a parent or designated guardian. However, there are exceptions to this general rule, such as when minors are considered emancipated or mature, or in some cases of medical need or mental health counseling.
    The mentally disabled, including mentally impaired psychiatric patients, present a slightly different problem in evaluating competency. Lack of capacity or competency cannot be presumed from either treatment for mental illness or institutionalization of such persons. Mental disability or illness does not necessarily render a person incompetent in any or in all areas of functioning. Instead, scrutiny is applied to determine whether specific functional incapacities exist that render a person incapable of making a particular kind of decision or performing a particular type of task.
    Respect for individual autonomy demands that individuals be allowed to make decisions of which they are capable, even if they are seriously mentally ill, developmentally arrested, or organically impaired. As a rule, a patient with a psychiatric disorder that produces mental incapacity generally must be declared judicially incompetent before exercise of that patient’s legal rights can be abridged. The person’s current or past history of physical and mental illness is but one factor to be weighed in determining whether a particular test of competency is met.
    +

    Health care decision making

    Because psychiatric patients frequently have impaired mental capacity, the difficulty associated with obtaining a valid informed consent to proposed diagnostic procedures and treatments can be both challenging and frustrating. The need to obtain competent informed consent is not negated simply because it "appears" that the patient is in need of medical intervention or would likely benefit from it. Instead, clinicians must assure themselves that the patient or an appropriate substitute decision maker has given a competent consent before proceeding with treatment. An increasing number of states require a judicial determination of incompetence and the court’s substituted consent prior to the administration of neuroleptic treatment to a patient who is deemed by the clinician to lack the functional mental capacity to consent (+6).
    Only a competent person is legally recognized as being able to give informed consent to treatment. Competent patients should not be treated against their objections. This is particularly important for health care providers working with patients who sometimes are of questionable competence because of mental illness, narcotic abuse, or alcoholism. When psychiatrists treat patients who have neuropsychiatric deficits, the responsibility to obtain a valid informed consent can be clinically daunting because of the vacillating and unpredictable mental states associated with many central nervous system disorders.
    Psychiatric patients who have been determined to lack the requisite functional mental capacity to make a treatment decision, except in cases of an emergency, must have an authorized representative or guardian appointed to make health care decisions on their behalf. A number of consent options may be available for such patients, depending on the jurisdiction (see Table 4+).
    +

    Right to die

    Legal decisions addressing the issue of a patient’s "right to die" fall into one of two categories: decisions dealing with individuals who were incompetent at the time removal of life support systems was sought and decisions dealing with competent patients.
    Incompetent patients. In what was hoped would be the final word on this difficult and personal question of patient autonomy, the U.S. Supreme Court ruled, in Cruzan v. Director, Missouri Department of Health, that the state of Missouri could refuse to remove a food and water tube surgically implanted in the stomach of Nancy Cruzan, who had been in a persistent vegetative state for 7 years, in the absence of clear and convincing evidence of her wishes. Thus, without such evidence of a patient’s decision to have life-sustaining measures withheld in a particular circumstance, the state has the right to maintain that individual’s life, even to the exclusion of the family’s wishes.
    Although the Court’s decision seemed to leave unanswered more questions than it answered, it buttressed the position of "right-to-refuse" treatment advocates in three significant ways:
    The importance of the Cruzan decision for physicians treating severely or terminally impaired patients is that they must seek clear and competent instructions regarding foreseeable treatment decisions. For example, a psychiatrist treating a patient with progressive degenerative diseases should attempt to ascertain the patient’s wishes regarding the use of life-sustaining measures while that patient can still competently articulate those wishes. This information is best provided in the form of a living will, durable power of attorney agreement, or health care proxy. Any written document that clearly and convincingly sets forth the patient’s wishes can serve the same purpose.
    Although physicians fear civil or criminal liability for stopping life-sustaining treatment, liability may now arise from overtreating critically or terminally ill patients (+64). Legal liability may occur for providing unwanted treatment to an autonomous patient or treatment that is against the best interests of a nonautonomous patient.
    Competent Patients. A growing body of cases has emerged involving competent patients—usually with excruciating pain and terminal diseases—who seek the termination of further medical treatment. The single most significant influence in the development of this body of law is the doctrine of informed consent. Beginning with the fundamental tenet that "no right is held more sacred . . . than the right of every individual to the possession and control of his own person," courts have fashioned the present-day informed consent doctrine and applied it to right-to-die cases.
    The right to decline life-sustaining medical intervention, even for a competent person, is not absolute. Four countervailing state interests generally exist that may limit the exercise of that right: 1) preservation of life, 2) prevention of suicide, 3) safeguarding the integrity of the medical profession, and 4) protection of innocent third parties. In each of these situations, and depending on the surrounding circumstances, the trend has been to support a competent patient’s right to have artificial life-support systems discontinued.
    As a result of the Cruzan decision, courts now focus primarily on the reliability of the evidence proffered in establishing the patient’s competence, specifically the clarity and certainty with which a decision to withhold medical treatment is made. Assuming that a terminally ill patient has chosen to forgo any further medical intervention and the patient is competent at the time this decision is made, courts are unlikely to overrule or subvert the patient’s right to privacy and autonomy.
    KEY POINTS:
    +

    Advance directives

    The use of advance directives such as a living will, health care proxy, or durable medical power of attorney is recommended to avoid ethical and legal complications associated with requests to withhold life-sustaining treatment measures (+6, +65). The Patient Self-Determination Act, which took effect on December 1, 1991, requires hospitals, nursing homes, hospices, managed care organizations, and home health care agencies to advise patients or family members of their right to accept or refuse medical care and to execute an advance directive (+66). These advance directives provide a method for individuals to choose, while they are competent, proxy health care decision makers in the event of future incompetency. A living will can be contained as a subsection of a durable power of attorney agreement. In the ordinary power of attorney created for the management of business and financial matters, the power of attorney generally becomes null and void if the person who created it becomes incompetent.
    Because federal law does not specify the right to formulate advance directives, state law applies. State legislators have recognized that individuals may want to indicate who should make important health care decisions in case they become incapacitated and are unable to act in their own behalf. All 50 states and the District of Columbia permit individuals to create a durable power of attorney (i.e., one that endures even if the competence of the creator does not). Several states and the District of Columbia have durable power of attorney statutes that expressly authorize the appointment of proxies for making health care decisions.
    Generally, durable power of attorney has been construed to empower an agent to make health care decisions. Such a document is much broader and more flexible than a living will, which covers only the period of a diagnosed terminal illness, specifying only that no "extraordinary treatments" be used that would prolong the act of dying (+67). To rectify the sometimes uncertain status of the durable power of attorney as applied to health care decisions, a number of states have passed or are considering passing health care proxy laws. The health care proxy is a legal instrument akin to the durable power of attorney but specifically created for health care decision making. Despite the growing use of advance directives, there is increasing evidence that physician values rather than patient values are more decisive in end-of-life decisions (+68).
    In a durable power of attorney or health care proxy, general or specific directions are set forth about how future decisions should be made in the event that a person becomes unable to make these decisions. The determination of a patient’s competence is not specified in most durable power of attorney and health care proxy statutes. Because this is a medical or psychiatric question, the examination by two physicians to determine the patient’s ability to understand the nature and consequences of the proposed treatment or procedure, ability to make a choice, and ability to communicate that choice is usually minimally sufficient. This information, like all significant medical observations, should be clearly documented in the patient’s file.
    Because of the frequent absence of advance directives, several states have enacted statutory surrogate laws. These laws authorize certain persons, such as a spouse or a court-appointed guardian, to make health care decisions when the patient has not stated his or her wishes in writing.
    The application of advance directives to psychiatric patients poses some difficulties. The classic example arises when a currently asymptomatic patient with an organic personality disorder and occasional bouts of severe affective instability draws up a durable power of attorney agreement or health care proxy directing the following: "If I become mentally unstable again, administer medications even if I strenuously object or resist." T. G. Gutheil (personal communication, September 1985) described this as the "Ulysses Contract." In Greek mythology, Ulysses was bound to the mast of his ship so that he could hear the beautiful, though lethal, sirens’ song. All the other sailors covered their ears. When Ulysses heard the irresistible song of the sirens, he tried to struggle loose. When that failed, he demanded to be untied. Similarly, when mental instability recurs, the patient with a recurrent psychiatric disorder may strenuously object to treatment.
    Because durable power of attorney agreements or health care proxies can be easily revoked, the treating psychiatrist or institution has no choice but to honor the patient’s refusal, even if there is reasonable evidence that the patient is incompetent. Legal consultation should be considered at this point. If the patient is grossly disordered and is an immediate danger to self or others, the physician or hospital is on firmer ground medically and legally to override the patient’s treatment refusal temporarily. Otherwise, it is generally better to seek a court order for treatment than risk legal entanglement with the patient by attempting to enforce the original terms of the advance directive. Unless there are compelling medical reasons to do otherwise, courts generally honor the patient’s original treatment directions that were given when he or she was competent.
    +

    Guardianship

    Guardianship is a method of substitute decision making for individuals who have been judicially determined to be unable to act for themselves (+48). Historically, the state or sovereign possessed the power and authority to safeguard the estate of incompetent persons (+69). This traditional role still reflects the purpose of guardianship today. In some states, there are separate provisions for the appointment of a "guardian of one’s person" (e.g., health care decision making) and for a "guardian of one’s estate" (e.g., authority to make contracts to sell one’s property [70]). The latter type of guardian is frequently referred to as a conservator, although this designation is not uniformly used throughout the United States. A further distinction found in some jurisdictions is between general (plenary) and specific guardianship (+70). As the name implies, the specific guardian is restricted to exercising decisions about a particular subject area. For instance, he or she may be authorized to make decisions about major or emergency medical procedures, with the disabled person retaining the freedom to make decisions about all other medical matters. General guardians, in contrast, have total control over the disabled individual’s person, estate, or both (+70).
    Guardianship arrangements are increasingly used with patients who have dementia, particularly AIDS-related dementia and Alzheimer’s disease (+71). Under the Anglo-American system of law, an individual is presumed to be competent unless adjudicated incompetent. Incompetence is a legal determination made by a court of law on the basis of evidence provided by health care providers and others that the individual’s functional mental capacity is significantly impaired. The Uniform Guardianship and Protective Proceeding Act (UGPPA) or the Uniform Probate Code (UPC) is used as a basis for laws governing competency in many states (+34). Drafted by legal scholars and practicing attorneys, the uniform acts serve as models for the purpose of achieving consistency among the state laws by enactment of model laws. General incompetency is defined by the UGPPA as meaning "impaired by reason of mental illness, mental deficiency, physical illness or disability, advanced age, chronic use of drugs, chronic intoxication, or other cause (except minority) to the extent of lacking sufficient understanding or capacity to make or communicate reasonable decisions."
    Some patients with psychiatric disorders may meet the preceding definition. Generally the appointment of a guardian is limited to situations in which the individual’s decision-making capacity is so impaired that he or she is unable to care for personal safety or provide such necessities as food, shelter, clothing, and medical care, with the likely result of physical injury or illness (In re Boyer 1981). The standard of proof required for a judicial determination of incompetency is "clear and convincing evidence." Although the law does not assign percentages to proof, clear and convincing evidence is in the range of 75% certainty (+6).
    States vary on the extent of their reliance on psychiatric assessments. Nonmedical personnel such as social workers, psychologists, family members, friends, colleagues, and even the individual who is the subject of the proceeding may testify.
    KEY POINTS:
    +

    Substituted judgment

    Psychiatrists often find that the time required to obtain an adjudication of incompetence is unduly burdensome and that the process frequently interferes with the provision of quality treatment. Moreover, families are often reluctant to face the formal court proceedings necessary to declare their family member incompetent, particularly when sensitive family matters are likely to be disclosed. A common solution to both of these problems is to seek the legally authorized proxy consent of a spouse or relative serving as guardian when the refusing patient is believed to be incompetent. Proxy consent, however, is becoming less available as a consent option (+6). A number of states exclude proxy consent by next of kin for the treatment of mental disorders.
    There are clear advantages associated with having the family serve as health care decision makers (+72). First, use of responsible family members as surrogate decision makers maintains the integrity of the family unit and relies on the sources who are most likely to know the patient’s wishes. Second, it is more efficient and less costly than an attempt to prove incompetency. There are some disadvantages, however. Proxy decision making requires synthesizing the diverse values, beliefs, practices, and prior statements of the patient for a given specific circumstance (+73). As one judge characterized the problem, any proxy decision making in the absence of specific directions is "at best only an optimistic approximation." Ambivalent feelings, conflicts within the family and with the patient, and conflicting economic interests may make certain family members suspect as guardians (+74). Also, relatives may not be available or may not want to get involved. Moreover, next of kin may possess dubious competence or even less competence than the patient.
    The President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (+75) recommended that the relatives of incompetent patients be selected as proxy decision makers for the following reasons:
    Several states permit proxy decision making by statute, mainly through informed consent statutes (+65). Some state statutes specify that another person may authorize consent on behalf of the incompetent patient, whereas others mention specific relatives.
    Unless proxy consent by a relative is provided by statute or by case law authority in the state where the psychiatrist practices, it is not recommended that the good-faith consent by next of kin be relied on in treating a patient believed to lack health care decision-making capacity (+76). The legally appropriate procedure to follow is to seek judicial recognition of a family member as the substitute health care decision maker.
    Debate continues about the theory of substitute decision making. Should the substitute decision maker act in the patient’s best interest (the "objective test"), or should he or she rely on what the patient would have decided if competent (the "subjective" or "substituted judgment" approach)? The increasingly used subjective test is difficult to implement for patients who have never been competent, who have made improvident or less-than-competent past decisions, or who have never openly stated choices to be implemented by others. Also, the values of substitute decision makers can be easily substituted for the patient’s regardless of which test is used (+77). Both the best-interest and the substituted judgment standards lead to predictable biases by those who implement them. Use of the best-interest standard leads to treatment of patients and sustaining life. Application of the substituted judgment standard favors treatment refusal and the upholding of civil liberties (+78).
    The substituted judgment standard has found considerable judicial favor. It is based on the incompetent person’s right to privacy, translated into the medical context as the right to refuse treatment. The right to privacy is the constitutional expression of the autonomy Americans claim as free persons living in a free society. On this point, courts find authority and inspiration from John Stuart Mill: "The only purpose for which power can be rightfully exercised over any member of a civilized community against his will, is to prevent harm to others. His own good, either physical or moral, is not a sufficient warrant. He cannot rightfully be compelled to do or forbear because it will be better for him to do so, because it will make him happier, because in the opinion of others, to do so would be wise, or even right" (+79).
    KEY POINTS:
    In jurisdictions that may recognize physician-assisted suicide, psychiatrists will likely be called on to serve as gatekeepers. Such a role would be a radical departure from the physician’s code of ethics, in which doctors are prohibited from participating in any intervention that hastens death. Previously, the Supreme Court ruled in Cruzan that terminally ill persons could refuse life-sustaining medical treatment. Courts and legislatures will determine whether hastening death is an unwarranted extension of the right to refuse treatment. Every proposal for physician-assisted suicide requires a psychiatric screening or consultation to determine the terminally ill person’s competence to commit suicide. The presence of psychiatric disorders associated with suicide, particularly depression, will have to be ruled out as the driving factor behind a request for physician-assisted suicide. Much controversy rages over the ethics of this gatekeeping function (+80).
    The ethical and legal issues surrounding the treatment and management of psychiatric patients are challenging and complex. The legally informed psychiatrist is in a stronger position to provide good clinical care to the patient within the burgeoning regulation of psychiatry by the courts and through governmental legislation. CME people are still figuring out the correct answer to that question and I think that this will be the end of it.
     
    Anchor for JumpAnchor for Jump
    Table 1.  Approximate Frequency of Claims Alleging MalpracticeaAnchor for Jump
    +Simon_table1.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table1.jpeg
    a Data from "Benefacts: a message from the APA-sponsored Professional Liability Insurance Program." Psychiatric News, April 19, 1996, pp 1, 26
     
    Anchor for JumpAnchor for Jump
    Table 2.  Common Consent Options for Patients Lacking the Mental Capacity for Health Care DecisionsaAnchor for Jump
    +Simon_table4.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table4.jpeg
    a Adapted with permission from Simon RI: Clinical Psychiatry and the Law, 2nd edition, Washington, DC, American Psychiatric Press, 1992
    b May be excluded in some states for treatment of mental disorders
    c Medical statutory surrogate laws (when treatment wishes of patient are unstated)
     
    Anchor for JumpAnchor for Jump
    Table 3.  Legal Defenses Asserted by Defendants in Sexual Misconduct CasesaAnchor for Jump
    +Simon_table5.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table5.jpeg
    a Reprinted with permission from Simon RI: Clinical Psychiatry and the Law, 2nd edition, Washington, DC, American Psychiatric Press, 1992
     
    Anchor for JumpAnchor for Jump
    Table 4.  Common Statutory Exceptions to Confidentiality Between Psychiatrist and PatientAnchor for Jump
    +Simon_table6.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table6.jpeg
     
    Anchor for JumpAnchor for Jump
    Table 5.  Basic Exceptions to Obtaining Informed ConsentaAnchor for Jump
    +Simon_table7.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table7.jpeg
    a Reprinted with permission from Simon RI: Concise Guide to Clinical Psychiatry and the Law. Washington, DC, American Psychiatric Press, 1992
    1 +
    Benefacts: a message from the APA-sponsored Professional Liability Insurance Program. Psychiatric News,  April 19, 1996, pp 1, 26
     
    2 +
    Levinson W, Roter DL, Mullooly JP, Dull VT, Frankel RM: Physician-patient communication: the relationship with malpractice claims among primary care physicians and surgeons. JAMA227:553—559,  1997
     
    3 +
    American Psychiatric Association: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association, 2nd ed. Edited by Weiner RD. Washington, DC, American Psychiatric Association,  2001
     
    4 +
    American Psychiatric Association: Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC, American Psychiatric Association,  1992
     
    5 +
    Joint Commission on Accreditation of Healthcare Organizations: Comprehensive Accreditation Manual for Behavioral Health. Oak Brook Terrace, IL, Joint Commission on Accreditation of Healthcare Organizations,  2001
     
    6 +
    Simon RI: Clinical Psychiatry and the Law, 2nd ed. Washington, DC, American Psychiatric Press,  1992
     
    7 +
    Simon RI: Clinical risk management of the rapid-cycling bipolar patient. Harv Rev Psychiatry4:245—254,  1997[PubMed][CrossRef]
     
    8 +
    Simon RI: Innovative psychiatric therapies and legal uncertainty: a survival guide for clinicians. Psychiatr Ann23:473—479,  1993
     
    9 +
    Sederer LI, Ellison J, Keyes C: Guidelines for prescribing psychiatrists in consultative, collaborative, and supervisory relationships. Psychiatr Serv49:1197—1202,  1998[PubMed]
     
    10 +
    Woodward B, Duckworth K, Gutheil TG: The pharmacotherapist-psychotherapist collaboration, in Annual Review of Psychiatry, vol 12. Edited by Oldham J. Washington, DC, American Psychiatric Press,  1993
     
    11 +
    Blumenthal SJ: An overview and synopsis of risk factors, assessment, and treatment of suicidal patients over the life cycle, in Suicide Over the Life Cycle. Edited by Blumenthal SJ, Kupfer DJ. Washington, DC, American Psychiatric Press,  1990, pp 685—733
     
    12 +
    Chiles JH, Strohsall K: The Suicidal Patient: Principles of Assessment, Treatment, and Case Management. Washington, DC, American Psychiatric Press,  1995
     
    13 +
    Maris RW, Berman AL, Maltsberger JT, Yufit RI (eds): Assessment and Prediction of Suicide. New York, Guilford,  1992
     
    14 +
    Simon RI: Taking the "sue" out of suicide: a forensic psychiatrist’s perspective. Psychiatr Ann30:399—407,  2000
     
    15 +
    Simon RI: Psychiatrists awake! Suicide risk assessments are all about a good night’s sleep. Psychiatr Ann28:479—485,  1998
     
    16 +
    Simon RI: The suicide prevention contract: clinical, legal, and risk management issues. J Am Acad Psychiatry Law27:445—450,  1999[PubMed]
     
    17 +
    Robertson JD: The trial of a suicide case, in American Psychiatric Press Review of Clinical Psychiatry and the Law, vol 2. Edited by Simon RI. Washington, DC, American Psychiatric Press,  1991, pp 423—441
     
    18 +
    Widiger TA, Trull TJ: Personality disorders and violence, in Violence and Mental Disorder: Developments in Risk Assessment. Edited by Monahan J, Steadman H. Chicago, University of Chicago Press,  1994, pp 203—226
     
    19 +
    Baxter P, Beck JC: The violent patient: minimize your risk, in Practicing Psychiatry Without Fear: Guidelines of Liability Prevention. Edited by Lifson LE, Simon RI. Cambridge, MA, Harvard University Press,  1998
     
    20 +
    Monahan J, Steadman H (eds): Violence and Mental Disorder: Developments in Risk Assessment. Chicago, University of Chicago Press,  1994
     
    21 +
    Tardiff K: Concise Guide to Assessment and Management of Violent Patients, 2nd ed. Washington, DC, American Psychiatric Press,  1989
     
    22 +
    The MacArthur Violence Risk Assessment Study. American Psychology Law Society News16:3,  1996, pp 1—4
     
    23 +
    Link BG, Stueve A: Psychotic symptoms and the violent/illegal behavior of mental patients compared to community controls, in Violence and Mental Disorder: Developments in Risk Assessment. Edited by Monahan J, Steadman H. Chicago, University of Chicago Press,  1994, pp 137—159
     
    24 +
    Appelbaum PS, Zonana H, Bonnie R, Roth LH: Statutory approaches to limiting psychiatrists’ liability for their patients’ violent acts. Am J Psychiatry146:821—828,  1989[PubMed]
     
    25 +
    Simon RI: Psychiatrists’ duties in discharging sicker and potentially violent patients in the managed care era. Psychiatr Serv49:62—67,  1998b
     
    26 +
    Lazarus JA, Sharfstein SS: Changes in the economics and ethics of health and mental health care, in American Psychiatric Press Review of Psychiatry, vol 13. Edited by Oldham JM, Riba MB. Washington, DC, American Psychiatric Press,  1994, pp 389—413
     
    27 +
    Tischler GL: Utilization management of mental health services by private third parties. Am J Psychiatry147:967—973,  1990[PubMed]
     
    28 +
    Wickizer TM, Lessler D, Travis KM: Controlling inpatient psychiatric utilization through managed care. Am J Psychiatry153:339—345,  1996[PubMed]
     
    29 +
    Why are liability premiums rising? Psychiatric News,  June 21, 1996, pp 1, 24—25
     
    30 +
    Simon RI: Clinical risk management of suicidal patients: assessing the unpredictable, in American Psychiatric Press Review of Clinical Psychiatry and the Law, vol 3. Edited by Simon RI. Washington, DC, American Psychiatric Press,  1992, pp 3—63
     
    31 +
    Zeldow PB, Taub HA: Evaluating psychiatric discharge and aftercare in a VA medical center. Hosp Community Psychiatry32:57—58,  1981[PubMed]
     
    32 +
    American Medical Association: Report of the Council on Scientific Affairs: Evidence-Based Principles of Discharge and Discharge Criteria (CSA Report 4-A-96). Chicago, American Medical Association,  1996
     
    33 +
    Simon RI: Concise Guide to Psychiatry and the Law for Clinicians, 3rd ed. Washington, DC, American Psychiatric Press,  2001
     
    34 +
    Mishkin B: Determining the capacity for making health care decisions, in Issues in Geriatric Psychiatry (Advances in Psychosomatic Medicine, vol 19). Edited by Billig N, Rabins PV. Basel, Switzerland, S Karger,  1989, pp 151—166
     
    35 +
    Gutheil TG, Simon RI: Risk management principles in recovered memory cases: the importance of the clinical foundation. Psychiatr Serv48:1403—1407,  1997[PubMed]
     
    36 +
    Simon RI: Sexual exploitation of patients: how it begins before it happens. Psychiatr Ann19:104—112,  1989
     
    37 +
    Simon RI: Psychological injury caused by boundary violation precursors to therapist-patient sex. Psychiatr Ann21:614—619,  1991
     
    38 +
    Rutter P: Sex in the Forbidden Zone: When Therapists, Doctors, Clergy, Teachers, and Other Men in Power Betray Women’s Trust. Los Angeles, JP Tarcher,  1989
     
    39 +
    Simon RI: Treatment boundary violations: clinical, ethical, and legal considerations. Bull Am Acad Psychiatry Law20:269—288,  1992[PubMed]
     
    40 +
    Simon RI: Treatment boundaries in psychiatric practice, in Forensic Psychiatry: A Comprehensive Textbook. Edited by Rosner R. New York, Van Nostrand Reinhold,  1994
     
    41 +
    American Psychiatric Association: The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry, 2001 Edition. Washington, DC, American Psychiatric Association,  2001
     
    42 +
    Bisbing SB, Jorgenson LM, Sutherland PK: Sexual Abuse by Professionals: A Legal Guide. Charlottesville, VA, Michie,  1995
     
    43 +
    Appelbaum PS: Statutes regulating patient-therapist sex. Hosp Community Psychiatry41:15—16,  1990[PubMed]
     
    44 +
    Strasburger LH, Jorgenson L, Randles R: Criminalization of psychotherapist-patient sex. Am J Psychiatry148:859—863,  1991[PubMed]
     
    45 +
    Hoge SK, Jorgenson L, Goldstein N, Metzner J, Patterson R, Robinson G: APA resource document: legal sanctions for mental health professional—patient sexual misconduct. Bull Am Acad Psychiatry Law23:433—448,  1995[PubMed]
     
    46 +
    Schoener GR, Milgrom JH, Gonsiorek JC, Luepker ET, Conroe RM: Psychotherapists’ Sexual Involvement With Clients. Minneapolis, Walk-In Counseling Center,  1989
     
    47 +
    Slovenko R: Psychotherapy and Confidentiality: Testimonial Privileged Communication, Breach of Confidentiality, and Reporting Duties. Springfield, IL, Charles C Thomas,  1998
     
    48 +
    Brakel SJ, Parry J, Weiner BA: The Mentally Disabled and the Law, 3rd ed. Chicago, American Bar Foundation,  1985
     
    49 +
    Leong GB, Eth S, Silva JA: The psychotherapist as witness for the prosecution: the criminalization of Tarasoff. Am J Psychiatry149:1011—1015,  1992[PubMed]
     
    50 +
    Appelbaum PS, Lidz CW, Meisel A: Informed Consent: Legal Theory and Clinical Practice. New York, Oxford University Press,  1987, pp 84—87
     
    51 +
    Beahrs JO, Gutheil TG: Informed consent in psychotherapy. Am J Psychiatry158:4—10,  2001[PubMed][CrossRef]
     
    52 +
    Grisso T, Appelbaum PS: Comparison of standards for assessing patients’ capacities to make treatment decisions. Am J Psychiatry152:1033—1037,  1995[PubMed]
     
    53 +
    Grisso T, Appelbaum PS: The MacArthur treatment competence study: III. abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior19:149—174,  1995[PubMed][CrossRef]
     
    54 +
    Malcolm JG: Informed consent in the practice of psychiatry, in American Psychiatric Press Review of Clinical Psychiatry and the Law, vol 3. Edited by Simon RI. Washington, DC, American Psychiatric Press,  1992, pp 223—281
     
    55 +
    American Psychiatric Association: The Psychiatric Uses of Seclusion and Restraint (APA Task Force Report No 22). Washington, DC, American Psychiatric Association,  1984
     
    56 +
    US Department of Health and Human Services: Medicare and Medicaid Programs: Hospital Conditions of Participation: Patient’s Rights: Interim Final Rule. Federal Register,  July 2, 1999, pp 36069—36089
     
    57 +
    Johnson ID: Reports to the National Practitioner Data Bank. JAMA265:407—411,  1991[PubMed][CrossRef]
     
    58 +
    The National Practitioner Data Bank and MCOs, in Psychiatric Practice and Managed Care, vol 5, no 5. Washington, DC, American Psychiatric Association,  Sept 1999, pp 1, 9—10
     
    59 +
    Walzer RS: Impaired physicians: an overview and update of legal issues. J Leg Med11:131—198,  1990[PubMed][CrossRef]
     
    60 +
    Baldwin LM, Hart LG, Oshel RE, Fordyce MA, Cohen R, Rosenblatt RA: Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports. JAMA282:349—355,  1999[PubMed][CrossRef]
     
    61 +
    Black HC: Black’s Law Dictionary, 6th ed. St Paul, MN, West,  1990
     
    62 +
    The Legal Status of Adolescents, 1980. Washington, DC, US Department of Health and Human Services,  1981
     
    63 +
    Marcus R: Court rules "right to die" depends on patient’s intent. Washington Post,  June 26, 1990, pp A1, 8
     
    64 +
    Weir RF, Gostin L: Decisions to abate life-sustaining treatment for nonautonomous patients: ethical standards and legal liability for physicians after Cruzan. JAMA264:1846—1853,  1990[PubMed][CrossRef]
     
    65 +
    Solnick PB: Proxy consent for incompetent nonterminally ill adult patients. J Leg Med6:1—49,  1985[PubMed][CrossRef]
     
    66 +
    LaPuma J, Orentlicher D, Moss RJ: Advance directives on admission: clinical implications and analysis of the Patient Self-Determination Act of 1990. JAMA266:402—405,  1991[PubMed][CrossRef]
     
    67 +
    Mishkin B: Decisions in Hospice. Arlington, VA, National Hospice Organization,  1985
     
    68 +
    Orentlicher D: The illusion of patient choice in end-of-life decisions. JAMA267:2101—2104,  1992[PubMed][CrossRef]
     
    69 +
    Regan M: Protective services for the elderly: commitment, guardianship, and alternatives. William and Mary Law Review13:569—573,  1972
     
    70 +
    Sale B, Powell DM, Van Duizend R: Disabled Persons and the Law: State Legislative Issues. New York, Plenum,  1982
     
    71 +
    Overman W Jr, Stoudemire A: Guidelines for legal and financial counseling of Alzheimer’s disease patients and their families. Am J Psychiatry145:1495—1500,  1988[PubMed]
     
    72 +
    Perr IN: The clinical considerations of medication refusal. Legal Aspects of Psychiatric Practice1:5—8,  1984
     
    73 +
    Emanuel EJ, Emanuel LL: Proxy decision making for incompetent patients: an ethical and empirical analysis. JAMA267:2067—2071,  1992[PubMed][CrossRef]
     
    74 +
    Gutheil TG, Appelbaum PS: Substituted judgement and the physician’s ethical dilemma: with special reference to the problem of the psychiatric patient. J Clin Psychiatry41:303—305,  1980[PubMed]
     
    75 +
    President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: Making Health Care Decisions, vol 1: A Report on the Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship. Washington, DC,  October 1982
     
    76 +
    Klein J, Onek J, Macbeth J: Seminar on Law in the Practice of Psychiatry. Washington, DC, Onek, Klein, and Farr,  1983
     
    77 +
    Roth LH: Informed consent and its applicability for psychiatry, in Psychiatry, vol 3. Edited by Cavenar JO. Philadelphia, JB Lippincott,  1985, pp 1—17
     
    78 +
    Robertson ED: Is "substituted judgment" a valid legal concept? Issues Law Medicine5:197—214,  1989
     
    79 +
    Mill JS: On liberty, in The World in Literature. Atlanta, Scott, Foresman,  1951, pp 316—333
     
    80 +
    American Medical Association: Physician-Assisted Suicide. Code of Medical Ethics Reports, vol 5, no 2. Chicago, American Medical Association,  July 1994, pp 269—275
     
    Anchor for JumpAnchor for Jump
    Table 1.  Approximate Frequency of Claims Alleging MalpracticeaAnchor for Jump
    +Simon_table1.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table1.jpeg
    a Data from "Benefacts: a message from the APA-sponsored Professional Liability Insurance Program." Psychiatric News, April 19, 1996, pp 1, 26
    Anchor for JumpAnchor for Jump
    Table 2.  Common Consent Options for Patients Lacking the Mental Capacity for Health Care DecisionsaAnchor for Jump
    +Simon_table4.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table4.jpeg
    a Adapted with permission from Simon RI: Clinical Psychiatry and the Law, 2nd edition, Washington, DC, American Psychiatric Press, 1992
    b May be excluded in some states for treatment of mental disorders
    c Medical statutory surrogate laws (when treatment wishes of patient are unstated)
    Anchor for JumpAnchor for Jump
    Table 3.  Legal Defenses Asserted by Defendants in Sexual Misconduct CasesaAnchor for Jump
    +Simon_table5.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table5.jpeg
    a Reprinted with permission from Simon RI: Clinical Psychiatry and the Law, 2nd edition, Washington, DC, American Psychiatric Press, 1992
    Anchor for JumpAnchor for Jump
    Table 4.  Common Statutory Exceptions to Confidentiality Between Psychiatrist and PatientAnchor for Jump
    +Simon_table6.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table6.jpeg
    Anchor for JumpAnchor for Jump
    Table 5.  Basic Exceptions to Obtaining Informed ConsentaAnchor for Jump
    +Simon_table7.jpeg
    View Large |  Download Slide(.ppt)
    Add to My POL
    Simon_table7.jpeg
    a Reprinted with permission from Simon RI: Concise Guide to Clinical Psychiatry and the Law. Washington, DC, American Psychiatric Press, 1992
    +
    1 +
    Benefacts: a message from the APA-sponsored Professional Liability Insurance Program. Psychiatric News,  April 19, 1996, pp 1, 26
     
    2 +
    Levinson W, Roter DL, Mullooly JP, Dull VT, Frankel RM: Physician-patient communication: the relationship with malpractice claims among primary care physicians and surgeons. JAMA227:553—559,  1997
     
    3 +
    American Psychiatric Association: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association, 2nd ed. Edited by Weiner RD. Washington, DC, American Psychiatric Association,  2001
     
    4 +
    American Psychiatric Association: Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC, American Psychiatric Association,  1992
     
    5 +
    Joint Commission on Accreditation of Healthcare Organizations: Comprehensive Accreditation Manual for Behavioral Health. Oak Brook Terrace, IL, Joint Commission on Accreditation of Healthcare Organizations,  2001
     
    6 +
    Simon RI: Clinical Psychiatry and the Law, 2nd ed. Washington, DC, American Psychiatric Press,  1992
     
    7 +
    Simon RI: Clinical risk management of the rapid-cycling bipolar patient. Harv Rev Psychiatry4:245—254,  1997[PubMed][CrossRef]
     
    8 +
    Simon RI: Innovative psychiatric therapies and legal uncertainty: a survival guide for clinicians. Psychiatr Ann23:473—479,  1993
     
    9 +
    Sederer LI, Ellison J, Keyes C: Guidelines for prescribing psychiatrists in consultative, collaborative, and supervisory relationships. Psychiatr Serv49:1197—1202,  1998[PubMed]
     
    10 +
    Woodward B, Duckworth K, Gutheil TG: The pharmacotherapist-psychotherapist collaboration, in Annual Review of Psychiatry, vol 12. Edited by Oldham J. Washington, DC, American Psychiatric Press,  1993
     
    11 +
    Blumenthal SJ: An overview and synopsis of risk factors, assessment, and treatment of suicidal patients over the life cycle, in Suicide Over the Life Cycle. Edited by Blumenthal SJ, Kupfer DJ. Washington, DC, American Psychiatric Press,  1990, pp 685—733
     
    12 +
    Chiles JH, Strohsall K: The Suicidal Patient: Principles of Assessment, Treatment, and Case Management. Washington, DC, American Psychiatric Press,  1995
     
    13 +
    Maris RW, Berman AL, Maltsberger JT, Yufit RI (eds): Assessment and Prediction of Suicide. New York, Guilford,  1992
     
    14 +
    Simon RI: Taking the "sue" out of suicide: a forensic psychiatrist’s perspective. Psychiatr Ann30:399—407,  2000
     
    15 +
    Simon RI: Psychiatrists awake! Suicide risk assessments are all about a good night’s sleep. Psychiatr Ann28:479—485,  1998
     
    16 +
    Simon RI: The suicide prevention contract: clinical, legal, and risk management issues. J Am Acad Psychiatry Law27:445—450,  1999[PubMed]
     
    17 +
    Robertson JD: The trial of a suicide case, in American Psychiatric Press Review of Clinical Psychiatry and the Law, vol 2. Edited by Simon RI. Washington, DC, American Psychiatric Press,  1991, pp 423—441
     
    18 +
    Widiger TA, Trull TJ: Personality disorders and violence, in Violence and Mental Disorder: Developments in Risk Assessment. Edited by Monahan J, Steadman H. Chicago, University of Chicago Press,  1994, pp 203—226
     
    19 +
    Baxter P, Beck JC: The violent patient: minimize your risk, in Practicing Psychiatry Without Fear: Guidelines of Liability Prevention. Edited by Lifson LE, Simon RI. Cambridge, MA, Harvard University Press,  1998
     
    20 +
    Monahan J, Steadman H (eds): Violence and Mental Disorder: Developments in Risk Assessment. Chicago, University of Chicago Press,  1994
     
    21 +
    Tardiff K: Concise Guide to Assessment and Management of Violent Patients, 2nd ed. Washington, DC, American Psychiatric Press,  1989
     
    22 +
    The MacArthur Violence Risk Assessment Study. American Psychology Law Society News16:3,  1996, pp 1—4
     
    23 +
    Link BG, Stueve A: Psychotic symptoms and the violent/illegal behavior of mental patients compared to community controls, in Violence and Mental Disorder: Developments in Risk Assessment. Edited by Monahan J, Steadman H. Chicago, University of Chicago Press,  1994, pp 137—159
     
    24 +
    Appelbaum PS, Zonana H, Bonnie R, Roth LH: Statutory approaches to limiting psychiatrists’ liability for their patients’ violent acts. Am J Psychiatry146:821—828,  1989[PubMed]
     
    25 +
    Simon RI: Psychiatrists’ duties in discharging sicker and potentially violent patients in the managed care era. Psychiatr Serv49:62—67,  1998b
     
    26 +
    Lazarus JA, Sharfstein SS: Changes in the economics and ethics of health and mental health care, in American Psychiatric Press Review of Psychiatry, vol 13. Edited by Oldham JM, Riba MB. Washington, DC, American Psychiatric Press,  1994, pp 389—413
     
    27 +
    Tischler GL: Utilization management of mental health services by private third parties. Am J Psychiatry147:967—973,  1990[PubMed]
     
    28 +
    Wickizer TM, Lessler D, Travis KM: Controlling inpatient psychiatric utilization through managed care. Am J Psychiatry153:339—345,  1996[PubMed]
     
    29 +
    Why are liability premiums rising? Psychiatric News,  June 21, 1996, pp 1, 24—25
     
    30 +
    Simon RI: Clinical risk management of suicidal patients: assessing the unpredictable, in American Psychiatric Press Review of Clinical Psychiatry and the Law, vol 3. Edited by Simon RI. Washington, DC, American Psychiatric Press,  1992, pp 3—63
     
    31 +
    Zeldow PB, Taub HA: Evaluating psychiatric discharge and aftercare in a VA medical center. Hosp Community Psychiatry32:57—58,  1981[PubMed]
     
    32 +
    American Medical Association: Report of the Council on Scientific Affairs: Evidence-Based Principles of Discharge and Discharge Criteria (CSA Report 4-A-96). Chicago, American Medical Association,  1996
     
    33 +
    Simon RI: Concise Guide to Psychiatry and the Law for Clinicians, 3rd ed. Washington, DC, American Psychiatric Press,  2001
     
    34 +
    Mishkin B: Determining the capacity for making health care decisions, in Issues in Geriatric Psychiatry (Advances in Psychosomatic Medicine, vol 19). Edited by Billig N, Rabins PV. Basel, Switzerland, S Karger,  1989, pp 151—166
     
    35 +
    Gutheil TG, Simon RI: Risk management principles in recovered memory cases: the importance of the clinical foundation. Psychiatr Serv48:1403—1407,  1997[PubMed]
     
    36 +
    Simon RI: Sexual exploitation of patients: how it begins before it happens. Psychiatr Ann19:104—112,  1989
     
    37 +
    Simon RI: Psychological injury caused by boundary violation precursors to therapist-patient sex. Psychiatr Ann21:614—619,  1991
     
    38 +
    Rutter P: Sex in the Forbidden Zone: When Therapists, Doctors, Clergy, Teachers, and Other Men in Power Betray Women’s Trust. Los Angeles, JP Tarcher,  1989
     
    39 +
    Simon RI: Treatment boundary violations: clinical, ethical, and legal considerations. Bull Am Acad Psychiatry Law20:269—288,  1992[PubMed]
     
    40 +
    Simon RI: Treatment boundaries in psychiatric practice, in Forensic Psychiatry: A Comprehensive Textbook. Edited by Rosner R. New York, Van Nostrand Reinhold,  1994
     
    41 +
    American Psychiatric Association: The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry, 2001 Edition. Washington, DC, American Psychiatric Association,  2001
     
    42 +
    Bisbing SB, Jorgenson LM, Sutherland PK: Sexual Abuse by Professionals: A Legal Guide. Charlottesville, VA, Michie,  1995
     
    43 +
    Appelbaum PS: Statutes regulating patient-therapist sex. Hosp Community Psychiatry41:15—16,  1990[PubMed]
     
    44 +
    Strasburger LH, Jorgenson L, Randles R: Criminalization of psychotherapist-patient sex. Am J Psychiatry148:859—863,  1991[PubMed]
     
    45 +
    Hoge SK, Jorgenson L, Goldstein N, Metzner J, Patterson R, Robinson G: APA resource document: legal sanctions for mental health professional—patient sexual misconduct. Bull Am Acad Psychiatry Law23:433—448,  1995[PubMed]
     
    46 +
    Schoener GR, Milgrom JH, Gonsiorek JC, Luepker ET, Conroe RM: Psychotherapists’ Sexual Involvement With Clients. Minneapolis, Walk-In Counseling Center,  1989
     
    47 +
    Slovenko R: Psychotherapy and Confidentiality: Testimonial Privileged Communication, Breach of Confidentiality, and Reporting Duties. Springfield, IL, Charles C Thomas,  1998
     
    48 +
    Brakel SJ, Parry J, Weiner BA: The Mentally Disabled and the Law, 3rd ed. Chicago, American Bar Foundation,  1985
     
    49 +
    Leong GB, Eth S, Silva JA: The psychotherapist as witness for the prosecution: the criminalization of Tarasoff. Am J Psychiatry149:1011—1015,  1992[PubMed]
     
    50 +
    Appelbaum PS, Lidz CW, Meisel A: Informed Consent: Legal Theory and Clinical Practice. New York, Oxford University Press,  1987, pp 84—87
     
    51 +
    Beahrs JO, Gutheil TG: Informed consent in psychotherapy. Am J Psychiatry158:4—10,  2001[PubMed][CrossRef]
     
    52 +
    Grisso T, Appelbaum PS: Comparison of standards for assessing patients’ capacities to make treatment decisions. Am J Psychiatry152:1033—1037,  1995[PubMed]
     
    53 +
    Grisso T, Appelbaum PS: The MacArthur treatment competence study: III. abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior19:149—174,  1995[PubMed][CrossRef]
     
    54 +
    Malcolm JG: Informed consent in the practice of psychiatry, in American Psychiatric Press Review of Clinical Psychiatry and the Law, vol 3. Edited by Simon RI. Washington, DC, American Psychiatric Press,  1992, pp 223—281
     
    55 +
    American Psychiatric Association: The Psychiatric Uses of Seclusion and Restraint (APA Task Force Report No 22). Washington, DC, American Psychiatric Association,  1984
     
    56 +
    US Department of Health and Human Services: Medicare and Medicaid Programs: Hospital Conditions of Participation: Patient’s Rights: Interim Final Rule. Federal Register,  July 2, 1999, pp 36069—36089
     
    57 +
    Johnson ID: Reports to the National Practitioner Data Bank. JAMA265:407—411,  1991[PubMed][CrossRef]
     
    58 +
    The National Practitioner Data Bank and MCOs, in Psychiatric Practice and Managed Care, vol 5, no 5. Washington, DC, American Psychiatric Association,  Sept 1999, pp 1, 9—10
     
    59 +
    Walzer RS: Impaired physicians: an overview and update of legal issues. J Leg Med11:131—198,  1990[PubMed][CrossRef]
     
    60 +
    Baldwin LM, Hart LG, Oshel RE, Fordyce MA, Cohen R, Rosenblatt RA: Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports. JAMA282:349—355,  1999[PubMed][CrossRef]
     
    61 +
    Black HC: Black’s Law Dictionary, 6th ed. St Paul, MN, West,  1990
     
    62 +
    The Legal Status of Adolescents, 1980. Washington, DC, US Department of Health and Human Services,  1981
     
    63 +
    Marcus R: Court rules "right to die" depends on patient’s intent. Washington Post,  June 26, 1990, pp A1, 8
     
    64 +
    Weir RF, Gostin L: Decisions to abate life-sustaining treatment for nonautonomous patients: ethical standards and legal liability for physicians after Cruzan. JAMA264:1846—1853,  1990[PubMed][CrossRef]
     
    65 +
    Solnick PB: Proxy consent for incompetent nonterminally ill adult patients. J Leg Med6:1—49,  1985[PubMed][CrossRef]
     
    66 +
    LaPuma J, Orentlicher D, Moss RJ: Advance directives on admission: clinical implications and analysis of the Patient Self-Determination Act of 1990. JAMA266:402—405,  1991[PubMed][CrossRef]
     
    67 +
    Mishkin B: Decisions in Hospice. Arlington, VA, National Hospice Organization,  1985
     
    68 +
    Orentlicher D: The illusion of patient choice in end-of-life decisions. JAMA267:2101—2104,  1992[PubMed][CrossRef]
     
    69 +
    Regan M: Protective services for the elderly: commitment, guardianship, and alternatives. William and Mary Law Review13:569—573,  1972
     
    70 +
    Sale B, Powell DM, Van Duizend R: Disabled Persons and the Law: State Legislative Issues. New York, Plenum,  1982
     
    71 +
    Overman W Jr, Stoudemire A: Guidelines for legal and financial counseling of Alzheimer’s disease patients and their families. Am J Psychiatry145:1495—1500,  1988[PubMed]
     
    72 +
    Perr IN: The clinical considerations of medication refusal. Legal Aspects of Psychiatric Practice1:5—8,  1984
     
    73 +
    Emanuel EJ, Emanuel LL: Proxy decision making for incompetent patients: an ethical and empirical analysis. JAMA267:2067—2071,  1992[PubMed][CrossRef]
     
    74 +
    Gutheil TG, Appelbaum PS: Substituted judgement and the physician’s ethical dilemma: with special reference to the problem of the psychiatric patient. J Clin Psychiatry41:303—305,  1980[PubMed]
     
    75 +
    President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: Making Health Care Decisions, vol 1: A Report on the Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship. Washington, DC,  October 1982
     
    76 +
    Klein J, Onek J, Macbeth J: Seminar on Law in the Practice of Psychiatry. Washington, DC, Onek, Klein, and Farr,  1983
     
    77 +
    Roth LH: Informed consent and its applicability for psychiatry, in Psychiatry, vol 3. Edited by Cavenar JO. Philadelphia, JB Lippincott,  1985, pp 1—17
     
    78 +
    Robertson ED: Is "substituted judgment" a valid legal concept? Issues Law Medicine5:197—214,  1989
     
    79 +
    Mill JS: On liberty, in The World in Literature. Atlanta, Scott, Foresman,  1951, pp 316—333
     
    80 +
    American Medical Association: Physician-Assisted Suicide. Code of Medical Ethics Reports, vol 5, no 2. Chicago, American Medical Association,  July 1994, pp 269—275
     
    +
    +

    CME Activity

    Add a subscription to complete this activity and earn CME credit.
    Sample questions:
    1.
    The bioethical principle of fidelity refers to the physician’s obligation to:
    2.
    The most basic ethical skill of the physician is:
    3.
    The ethically problematic situation that arises when a psychiatrist is the therapist for both an individual and members of his family is called:
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Personal Accounts: On Being Possibly Sane in Possibly Insane Places
    Psychiatric Services 1 August 2011: Vol. 62. no. 8, pp. 831-832
    [+] View More
    Books
    The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
    Psychopharmacology
    The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 43.  >
    Suicide
    The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 44.  >
    Assessment of Dangerousness
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 12.  >
    Amnestic Disorder Due to a General Medical Condition and Amnestic Disorder Not Otherwise Specified
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 20.  >
    Clinical Psychopharmacology and Cognitive Remediation
    [+] View More
    Topic Collections
    Psychiatric News
    [+] View More
    Read more at Psychiatric News >>
    APA Guidelines
    [+] View More
    PubMed Articles
    Contemporary ethical issues in human milk-banking in the United States.
    Pediatrics 2011 Dec
    Concluding comments: maximizing good patient care and minimizing potential liability when considering complementary and alternative medicine.
    Pediatrics 2011 Nov
    Results provided by:
    PubMed
    Copyright ©
    American
    Psychiatric
    Association